{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Medical Entity Recognition"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We will be looking at using multiple entities in our dataset, attempting to improve on the Bidirectional LSTM and further exploration"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Import Libraries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Using TensorFlow backend.\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "from sklearn.model_selection import train_test_split\n",
    "\n",
    "import tensorflow\n",
    "\n",
    "from keras.preprocessing.sequence import pad_sequences\n",
    "from keras.utils import to_categorical\n",
    "\n",
    "from tensorflow.keras import Sequential, Model, Input\n",
    "from tensorflow.keras.layers import LSTM, Embedding, Dense, TimeDistributed, Dropout, Bidirectional\n",
    "from tensorflow.keras.utils import plot_model\n",
    "from tensorflow.keras.callbacks import ModelCheckpoint, ReduceLROnPlateau, EarlyStopping\n",
    "from tensorflow.keras.optimizers import Adam, SGD"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Load and Parse Data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Dataset is slightly more difficult to parse when loaded using pandas hence will use pandas results for convenience when building custom parser. Also use pandas df to build relevant dictionaries for convenience."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "train_dev_data = pd.read_csv(\"NERdata/NCBI-disease/train_dev.tsv\", sep = \"\\t\", header = None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "      <th>1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Identification</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>of</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>APC2</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>,</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>a</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>homologue</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>of</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>the</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>adenomatous</td>\n",
       "      <td>B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>polyposis</td>\n",
       "      <td>I</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>coli</td>\n",
       "      <td>I</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>tumour</td>\n",
       "      <td>I</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>suppressor</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>.</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>The</td>\n",
       "      <td>O</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>adenomatous</td>\n",
       "      <td>B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>polyposis</td>\n",
       "      <td>I</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>coli</td>\n",
       "      <td>I</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>(</td>\n",
       "      <td>I</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>APC</td>\n",
       "      <td>I</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 0  1\n",
       "0   Identification  O\n",
       "1               of  O\n",
       "2             APC2  O\n",
       "3                ,  O\n",
       "4                a  O\n",
       "5        homologue  O\n",
       "6               of  O\n",
       "7              the  O\n",
       "8      adenomatous  B\n",
       "9        polyposis  I\n",
       "10            coli  I\n",
       "11          tumour  I\n",
       "12      suppressor  O\n",
       "13               .  O\n",
       "14             The  O\n",
       "15     adenomatous  B\n",
       "16       polyposis  I\n",
       "17            coli  I\n",
       "18               (  I\n",
       "19             APC  I"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_dev_data.head(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_data(file_path):\n",
    "    file = open(file_path, \"r\")\n",
    "    data, entities, sentence, unique_labels = [], [], [], []\n",
    "    for line in file:\n",
    "        line = line.strip(\"\\n\").split(\"\\t\")\n",
    "        \n",
    "        if len(line) > 1:\n",
    "            word = line[0]\n",
    "            label = line[1]\n",
    "            \n",
    "            sentence.append(word)\n",
    "            entities.append(label)\n",
    "            \n",
    "            if label not in unique_labels:\n",
    "                unique_labels.append(label)\n",
    "            \n",
    "        elif len(entities) > 0:\n",
    "            sentence = \" \".join(sentence)\n",
    "            data.append({\"sentence\" : sentence, \"entities\" : entities})\n",
    "            entities, sentence = [], []\n",
    "            \n",
    "    file.close()\n",
    "    return data, unique_labels"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "filepath = \"NERdata/NCBI-disease/train_dev.tsv\"\n",
    "\n",
    "data, unq_labels = load_data(filepath)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'sentence': 'Identification of APC2 , a homologue of the adenomatous polyposis coli tumour suppressor .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The adenomatous polyposis coli ( APC ) tumour - suppressor protein controls the Wnt signalling pathway by forming a complex with glycogen synthase kinase 3beta ( GSK - 3beta ) , axin / conductin and betacatenin .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Complex formation induces the rapid degradation of betacatenin .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'In colon carcinoma cells , loss of APC leads to the accumulation of betacatenin in the nucleus , where it binds to and activates the Tcf - 4 transcription factor ( reviewed in [ 1 ] [ 2 ] ) .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Here , we report the identification and genomic structure of APC homologues .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mammalian APC2 , which closely resembles APC in overall domain structure , was functionally analyzed and shown to contain two SAMP domains , both of which are required for binding to conductin .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Like APC , APC2 regulates the formation of active betacatenin - Tcf complexes , as demonstrated using transient transcriptional activation assays in APC - / - colon carcinoma cells .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Human APC2 maps to chromosome 19p13 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '3 .', 'entities': ['O', 'O']},\n",
       " {'sentence': 'APC and APC2 may therefore have comparable functions in development and cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'A common MSH2 mutation in English and North American HNPCC families : origin , phenotypic expression , and sex specific differences in colorectal cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The frequency , origin , and phenotypic expression of a germline MSH2 gene mutation previously identified in seven kindreds with hereditary non - polyposis cancer syndrome ( HNPCC ) was investigated .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The mutation ( A - - > T at nt943 + 3 ) disrupts the 3 splice site of exon 5 leading to the deletion of this exon from MSH2 mRNA and represents the only frequent MSH2 mutation so far reported .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Although this mutation was initially detected in four of 33 colorectal cancer families analysed from eastern England , more extensive analysis has reduced the frequency to four of 52 ( 8 % ) English HNPCC kindreds analysed .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In contrast , the MSH2 mutation was identified in 10 of 20 ( 50 % ) separately identified colorectal families from Newfoundland .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To investigate the origin of this mutation in colorectal cancer families from England ( n = 4 ) , Newfoundland ( n = 10 ) , and the United States ( n = 3 ) , haplotype analysis using microsatellite markers linked to MSH2 was performed .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Within the English and US families there was little evidence for a recent common origin of the MSH2 splice site mutation in most families .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In contrast , a common haplotype was identified at the two flanking markers ( CA5 and D2S288 ) in eight of the Newfoundland families .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These findings suggested a founder effect within Newfoundland similar to that reported by others for two MLH1 mutations in Finnish HNPCC families .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We calculated age related risks of all , colorectal , endometrial , and ovarian cancers in nt943 + 3 A - - > T MSH2 mutation carriers ( n = 76 ) for all patients and for men and women separately .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'For both sexes combined , the penetrances at age 60 years for all cancers and for colorectal cancer were 0 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '86 and 0 .', 'entities': ['O', 'O', 'O', 'O']},\n",
       " {'sentence': '57 , respectively .', 'entities': ['O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The risk of colorectal cancer was significantly higher ( p < 0 . 01 ) in males than females ( 0 . 63 v 0 . 30 and 0 . 84 v 0 . 44 at ages 50 and 60 years , respectively ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'For females there was a high risk of endometrial cancer ( 0 . 5 at age 60 years ) and premenopausal ovarian cancer ( 0 . 2 at 50 years ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These intersex differences in colorectal cancer risks have implications for screening programmes and for attempts to identify colorectal cancer susceptibility modifiers .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Age of onset in Huntington disease : sex specific influence of apolipoprotein E genotype and normal CAG repeat length .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Age of onset ( AO ) of Huntington disease ( HD ) is known to be correlated with the length of an expanded CAG repeat in the HD gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Apolipoprotein E ( APOE ) genotype , in turn , is known to influence AO in Alzheimer disease , rendering the APOE gene a likely candidate to affect AO in other neurological diseases too .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We therefore determined APOE genotype and normal CAG repeat length in the HD gene for 138 HD patients who were previously analysed with respect to CAG repeat length .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Genotyping for APOE was performed blind to clinical information .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'In addition to highlighting the effect of the normal repeat length upon AO in maternally inherited HD and in male patients , we show that the APOE epsilon2epsilon3 genotype is associated with significantly earlier AO in males than in females .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Such a sex difference in AO was not apparent for any of the other APOE genotypes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our findings suggest that subtle differences in the course of the neurodegeneration in HD may allow interacting genes to exert gender specific effects upon AO .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The serum of a 29 - year old woman with a recent episode of disseminated gonococcal infection and a history of meningococcal meningitis and arthritis as a child was found to lack serum hemolytic complement activity .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The seventh component of complement ( C7 ) was not detected by functional or immunochemical assays , whereas other components were normal by hemolytic and immunochemical assessment .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Her fresh serum lacked complement - mediated bactericidal activity against Neisseria gonorrhoeae , but the addition of fresh normal serum or purified C7 restored bactericidal activity as well as hemolytic activity .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The absence of functional C7 activity could not be accounted for on the basis of an inhibitor .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Opsonization and generation of chemotactic activity functioned normally .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Complete absence of C7 was also found in one sibling who had the clinical syndrome of meningococcal meningitis and arthritis as a child and in this siblings clinically well eight - year - old son .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'HLA histocompatibility typing of the family members did not demonstrate evidence for genetic linkage of C7 deficiency with the major histocompatibility loci .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This report represents the first cases of C7 deficiency associated with infectious complications and suggests that bactericidal activity may be important in host defense against bacteremic neisseria infections .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Increased incidence of cancer in patients with cartilage - hair hypoplasia .',\n",
       "  'entities': ['O', 'O', 'O', 'B', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']},\n",
       " {'sentence': 'OBJECTIVE Previous reports have suggested an increased risk of cancer among patients with cartilage - hair hypoplasia ( CHH ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This study was carried out to further evaluate this risk among patients with CHH and their first - degree relatives .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'STUDY DESIGN One hundred twenty - two patients with CHH were identified through 2 countrywide epidemiologic surveys in 1974 and in 1986 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Their parents and nonaffected siblings were identified through the Population Register Center .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This cohort underwent follow - up for cancer incidence through the Finnish Cancer Registry to the end of 1995 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'RESULTS A statistically significant excess risk of cancer was seen among the patients with CHH ( standardized incidence ratio 6 . 9 , 95 % confidence interval 2 . 3 to 16 ) , which was mainly attributable to non - Hodgkins lymphoma ( standardized incidence ratio 90 , 95 % confidence interval 18 to 264 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In addition , a significant excess risk of basal cell carcinoma was seen ( standardized incidence ratio 35 , 95 % confidence interval 7 . 2 to 102 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The cancer incidence among the siblings or the parents did not differ from the average cancer incidence in the Finnish population .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'CONCLUSIONS This study confirms an increased risk of cancer , especially non - Hodgkins lymphoma , probably attributable to defective immunity , among patients with CHH .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']},\n",
       " {'sentence': 'Dihydropyrimidine dehydrogenase ( DPD ) deficiency is an autosomal recessive disease characterised by thymine - uraciluria in homozygous deficient patients and has been associated with a variable clinical phenotype .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In order to understand the genetic and phenotypic basis for DPD deficiency , we have reviewed 17 families presenting 22 patients with complete deficiency of DPD .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'In this group of patients , 7 different mutations have been identified , including 2 deletions [ 295 - 298delTCAT , 1897delC ] , 1 splice - site mutation [ IVS14 + 1G > A ) ] and 4 missense mutations ( 85T > C , 703C > T , 2658G > A , 2983G > T ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Analysis of the prevalence of the various mutations among DPD patients has shown that the G - - > A point mutation in the invariant splice donor site is by far the most common ( 52 % ) , whereas the other six mutations are less frequently observed .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A large phenotypic variability has been observed , with convulsive disorders , motor retardation and mental retardation being the most abundant manifestations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A clear correlation between the genotype and phenotype has not been established .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'An altered beta - alanine , uracil and thymine homeostasis might underlie the various clinical abnormalities encountered in patients with DPD deficiency .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Fibroblast growth factor homologous factor 2 ( FHF2 ) : gene structure , expression and mapping to the Borjeson - Forssman - Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS - like patient .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Borjeson - Forssman - Lehmann syndrome ( BFLS ) is a syndromal X - linked mental retardation , which maps by linkage to the q26 region of the human X chromosome .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have identified a male patient with BFLS - like features and a duplication , 46 , Y , dup ( X ) ( q26q28 ) , inherited from his phenotypically normal mother .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Fluorescence in situ hybridisation using yeast artificial chromosome clones from Xq26 localised the duplication breakpoint to an approximately 400 - kb interval in the Xq26 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '3 region between DXS155 and DXS294 / DXS730 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Database searches and analysis of available genomic DNA sequence from the region revealed the presence of the fibroblast growth factor homologous factor gene , FHF2 , within the duplication breakpoint interval .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The gene structure of FHF2 was determined and two new exons were identified , including a new 5 end exon , 1B .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'FHF2 is a large gene extending over approximately 200 kb in Xq26 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '3 and is composed of at least seven exons .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'It shows tissue - specific alternative splicing and alternative transcription starts .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Northern blot hybridisation showed highest expression in brain and skeletal muscle .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The FHF2 gene localisation and tissue - specific expression pattern suggest it to be a candidate gene for familial cases of the BFLS syndrome and other syndromal and non - specific forms of X - linked mental retardation mapping to the region .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Germline E - cadherin gene ( CDH1 ) mutations predispose to familial gastric cancer and colorectal cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Inherited mutations in the E - cadherin gene ( CDH1 ) were described recently in three Maori kindreds with familial gastric cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Familial gastric cancer is genetically heterogeneous and it is not clear what proportion of gastric cancer susceptibility in non - Maori populations is due to germline CDH1 mutations .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Therefore , we screened eight familial gastric cancer kindreds of British and Irish origin for germline CDH1 mutations , by SSCP analysis of all 16 exons and flanking sequences .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Each family contained ( i ) two cases of gastric cancer in first degree relatives with one affected before age 50 years ; or ( ii ) three or more cases of gastric cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Novel germline CDH1 mutations ( a nonsense and a splice site ) were detected in two families ( 25 % ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Both mutations were predicted to truncate the E - cadherin protein in the signal peptide domain .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In one family there was evidence of non - penetrance and susceptibility to both gastric and colorectal cancer ; thus , in addition to six cases of gastric cancer , a CDH1 mutation carrier developed colorectal cancer at age 30 years .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have confirmed that germline mutations in the CDH1 gene cause familial gastric cancer in non - Maori populations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'However , only a minority of familial gastric cancers can be accounted for by CDH1 mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Loss of E - cadherin function has been implicated in the pathogenesis of sporadic colorectal and other cancers , and our findings provide evidence that germline CDH1 mutations predispose to early onset colorectal cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Thus , CDH1 should be investigated as a cause of inherited susceptibility to both gastric and colorectal cancers .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys - Drash syndrome .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The Wilms tumor - suppressor gene , WT1 , plays a key role in urogenital development , and WT1 dysfunction is implicated in both neoplastic ( Wilms tumor , mesothelioma , leukemias , and breast cancer ) and nonneoplastic ( glomerulosclerosis ) disease .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The analysis of diseases linked specifically with WT1 mutations , such as Denys - Drash syndrome ( DDS ) , can provide valuable insight concerning the role of WT1 in development and disease .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'DDS is a rare childhood disease characterized by a nephropathy involving mesangial sclerosis , XY pseudohermaphroditism , and / or Wilms tumor ( WT ) .',\n",
       "  'entities': ['B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'DDS patients are constitutionally heterozygous for exonic point mutations in WT1 , which include mutations predicted to truncate the protein within the C - terminal zinc finger ( ZF ) region .',\n",
       "  'entities': ['B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We report that heterozygosity for a targeted murine Wt1 allele , Wt1 ( tmT396 ) , which truncates ZF3 at codon 396 , induces mesangial sclerosis characteristic of DDS in adult heterozygous and chimeric mice .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Male genital defects also were evident and there was a single case of Wilms tumor in which the transcript of the nontargeted allele showed an exon 9 skipping event , implying a causal link between Wt1 dysfunction and Wilms tumorigenesis in mice .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'However , the mutant WT1 ( tmT396 ) protein accounted for only 5 % of WT1 in both heterozygous embryonic stem cells and the WT .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'This has implications regarding the mechanism by which the mutant allele exerts its effect .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mechanism of increased iron absorption in murine model of hereditary hemochromatosis : increased duodenal expression of the iron transporter DMT1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Hereditary hemochromatosis ( HH ) is a common autosomal recessive disorder characterized by tissue iron deposition secondary to excessive dietary iron absorption .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We recently reported that HFE , the protein defective in HH , was physically associated with the transferrin receptor ( TfR ) in duodenal crypt cells and proposed that mutations in HFE attenuate the uptake of transferrin - bound iron from plasma by duodenal crypt cells , leading to up - regulation of transporters for dietary iron .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Here , we tested the hypothesis that HFE - / - mice have increased duodenal expression of the divalent metal transporter ( DMT1 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'By 4 weeks of age , the HFE - / - mice demonstrated iron loading when compared with HFE + / + littermates , with elevated transferrin saturations ( 68 . 4 % vs . 49 . 8 % ) and elevated liver iron concentrations ( 985 micrograms vs . 381 micrograms ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'By using Northern blot analyses , we quantitated duodenal expression of both classes of DMT1 transcripts one containing an iron responsive element ( IRE ) , called DMT1 ( IRE ) , and one containing no IRE , called DMT1 ( non - IRE ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The positive control for DMT1 up - regulation was a murine model of dietary iron deficiency that demonstrated greatly increased levels of duodenal DMT1 ( IRE ) mRNA .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'HFE - / - mice also demonstrated an increase in duodenal DMT1 ( IRE ) mRNA ( average 7 . 7 - fold ) , despite their elevated transferrin saturation and hepatic iron content .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Duodenal expression of DMT1 ( non - IRE ) was not increased , nor was hepatic expression of DMT1 increased .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These data support the model for HH in which HFE mutations lead to inappropriately low crypt cell iron , with resultant stabilization of DMT1 ( IRE ) mRNA , up - regulation of DMT1 , and increased absorption of dietary iron .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Neurophysiologic follow - up of long - term dietary treatment in adult - onset adrenoleukodystrophy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'OBJECTIVE To monitor the effects of dietary treatment in adult - onset adrenoleukodystrophy ( ALD ) by means of somatosensory evoked potentials ( SEPs ) and motor evoked potentials ( MEPs ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'BACKGROUND SEPs and MEPs have proved useful in revealing signs of progressively severe , central dying - back axonopathy in early stages of adult - onset ALD .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'METHODS Eight patients with adult - onset ALD underwent clinical examination , brain and spine MRI , and SEP and MEP studies before and after 3 years of Lorenzos oil dietary therapy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'RESULTS Before treatment , brain MRI was normal in five patients .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Three of these patients had pure spinal SEP abnormalities and in the remaining two patients SEPs showed signs of involvement of both the spinal and cerebral somatosensory tracts .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'After treatment , the three patients with pure spinal abnormalities showed clinical and neurophysiologic worsening , whereas the two patients with a more advanced stage of disease ( exhibited by SEPs ) showed substantially unchanged clinical and neurophysiologic features .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The patients with abnormal brain MRI at the onset of treatment showed clinical and neurophysiologic worsening .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'CONCLUSIONS Lorenzos oil therapy had no effect on patients with evidence of inflammatory brain lesions .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Moreover , in patients without clear signs of inflammatory damage , this treatment does not modify significantly the natural course of the disease .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'However , because effective treatments should begin before the onset of severe neurologic symptoms , SEPs and MEPs should be considered to evaluate the effectiveness of other experimental treatments in the patient with a negative brain MRI .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'GCH1 mutation in a patient with adult - onset oromandibular dystonia .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']},\n",
       " {'sentence': 'The authors report a mutation in exon 5 of GCH1 in a patient with adult - onset oromandibular dystonia and no obvious family history of dystonia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The patient responded positively to treatment with L - dopa .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'These findings demonstrate that GCH1 mutations must be considered even in patients with dystonic symptoms not typical of dopa - responsive dystonia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Germline mutations of the APC gene in Korean familial adenomatous polyposis patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We extensively analyzed genomic DNA and messenger RNA ( mRNA ) from 62 unrelated Korean patients with familial adenomatous polyposis ( FAP ) for identification of germline adenomatous polyposis coli ( APC ) gene mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We adopted both single - strand conformation polymorphism ( SSCP ) analysis and a method of analysis involving the reverse transcription - polymerase chain reaction ( RT - PCR ) followed by a protein truncation test ( PTT ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'DNA sequencing confirmed all alterations represented by aberrant bands .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Germline mutations were identified in 38 patients ( 61 % ) .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Nineteen of the detected mutations were presumed to be novel , thus emphasizing the heterogeneity of the mutational spectrum in Korean FAP patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In the initial 48 patients , SSCP analysis was followed by PTT for those patients for whom no detectable mutations were found by SSCP .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Using this combined approach , we identified germline APC gene mutations in 29 of the 48 FAP patients ( 60 % ) , including 6 patients in whom SSCP analysis failed to distinguish the mutant allele .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In the 14 later patients , we identified truncating mutations in 9 patients ( 64 % ) using PTT only .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our results confirm that the mutation detection rate with PTT was superior to that with SSCP , and suggest that PTT would be a more practical screening method to detect germline mutations of the APC gene in FAP patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Molecular epidemiology of C9 deficiency heterozygotes with an Arg95Stop mutation of the C9 gene in Japan .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Deficiency of the ninth component of human complement ( C9 ) is the most common complement deficiency in Japan , with an incidence of approximately one homozygote in 1000 , but is very rare in other countries .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Genetic analyses of Japanese C9 deficiency have shown that a C - to - T transition leading to TGA stop codon for Arg95 in exon 4 of the C9 gene ( Arg95Stop ) is common in Japanese C9 deficiency .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'To determine the prevalence of heterozygous carriers of the Arg95Stop mutation in a Japanese population , we collected DNA samples from 300 individuals in two of the four main islands of Japan .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Heterozygote detection was performed with an allele - specific polymerase chain reaction ( PCR ) system designed to detect exclusively only one of the normal and mutant alleles , followed by confirmation with PCR / single - strand conformation polymorphism ( SSCP ) analysis and direct sequencing .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Twenty individuals were heterozygous for the Arg95Stop mutation .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'None was homozygous .', 'entities': ['O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The prevalence of carriers of the Arg95Stop mutation was 6 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '7 % ( 20 / 300 ) .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'An estimated frequency ( 0 . 12 % ) of complete C9 deficiency due to homozygous Arg95Stop mutation was consistent with frequencies determined by serological studies',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The hereditary hemochromatosis protein , HFE , specifically regulates transferrin - mediated iron uptake in HeLa cells .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'HFE is the protein product of the gene mutated in the autosomal recessive disease hereditary hemochromatosis ( Feder , J .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'N . , Gnirke , A . , Thomas , W . , Tsuchihashi , Z . , Ruddy , D .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A . , Basava , A . , Dormishian , F . , Domingo , R .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'J . , Ellis , M .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'C . , Fullan , A . , Hinton , L .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'M . , Jones , N .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'L . , Kimmel , B .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'E . , Kronmal , G .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'S . , Lauer , P . , Lee , V .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'K . , Loeb , D .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'B . , Mapa , F .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'A . , McClelland , E . , Meyer , N .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'C . , Mintier , G .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'A . , Moeller , N . , Moore , T . , Morikang , E . , Prasss , C .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'E . , Quintana , L . , Starnes , S .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'M . , Schatzman , R .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'C . , Brunke , K .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'J . , Drayna , D .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'T . , Risch , N .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'J . , Bacon , B .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'R . , and Wolff , R .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'R .', 'entities': ['O', 'O']},\n",
       " {'sentence': '( 1996 ) Nat .', 'entities': ['O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Genet .', 'entities': ['O', 'O']},\n",
       " {'sentence': '13 , 399 - 408 ) .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'At the cell surface , HFE complexes with transferrin receptor ( TfR ) , increasing the dissociation constant of transferrin ( Tf ) for its receptor 10 - fold ( Gross , C .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'N . , Irrinki , A . , Feder , J . N . , and Enns , C . A . ( 1998 ) J . Biol . Chem . 273 , 22068 - 22074 ; Feder , J . N . , Penny , D . M . , Irrinki , A . , Lee , V . K . , Lebron , J . A . , Watson , N . , Tsuchihashi , Z . , Sigal , E . , Bjorkman , P . J . , and Schatzman , R . C . ( 1998 ) Proc . Natl .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Acad .', 'entities': ['O', 'O']},\n",
       " {'sentence': 'Sci .', 'entities': ['O', 'O']},\n",
       " {'sentence': 'U S A 95 , 1472 - 1477 ) .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'HFE does not remain at the cell surface , but traffics with TfR to Tf - positive internal compartments ( Gross et al . , 1998 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Using a HeLa cell line in which the expression of HFE is controlled by tetracycline , we show that the expression of HFE reduces 55Fe uptake from Tf by 33 % but does not affect the endocytic or exocytic rates of TfR cycling .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Therefore , HFE appears to reduce cellular acquisition of iron from Tf within endocytic compartments .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'HFE specifically reduces iron uptake from Tf , as non - Tf - mediated iron uptake from Fe - nitrilotriacetic acid is not altered .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These results explain the decreased ferritin levels seen in our HeLa cell system and demonstrate the specific control of HFE over the Tf - mediated pathway of iron uptake .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These results also have implications for the understanding of cellular iron homeostasis in organs such as the liver , pancreas , heart , and spleen that are iron loaded in hereditary hemochromatotic individuals lacking functional HFE .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Familial Mediterranean fever ( FMF ) is a recessive disorder characterized by episodes of fever with serositis or synovitis .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The FMF gene ( MEFV ) was cloned recently , and four missense mutations were identified .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Here we present data from non - Ashkenazi Jewish and Arab patients in whom we had not originally found mutations and from a new , more ethnically diverse panel .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Among 90 symptomatic mutation - positive individuals , 11 mutations accounted for 79 % of carrier chromosomes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Of the two mutations that are novel , one alters the same residue ( 680 ) as a previously known mutation , and the other ( P369S ) is located in exon 3 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Consistent with another recent report , the E148Q mutation was observed in patients of several ethnicities and on multiple microsatellite haplotypes , but haplotype data indicate an ancestral relationships between non - Jewish Italian and Ashkenazi Jewish patients with FMF and other affected populations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Among approximately 200 anonymous Ashkenazi Jewish DNA samples , the MEFV carrier frequency was 21 % , with E148Q the most common mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Several lines of evidence indicate reduced penetrance among Ashkenazi Jews , especially for E148Q , P369S , and K695R .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Nevertheless , E148Q helps account for recessive inheritance in an Ashkenazi family previously reported as an unusual case of dominantly inherited FMF .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The presence of three frequent MEFV mutations in multiple Mediterranean populations strongly suggests a heterozygote advantage in this geographic region .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Autoimmune lymphoproliferative syndrome with defective Fas : genotype influences penetrance .',\n",
       "  'entities': ['B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Autoimmune lymphoproliferative syndrome ( ALPS ) is a disorder of lymphocyte homeostasis and immunological tolerance .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Most patients have a heterozygous mutation in the APT1 gene , which encodes Fas ( CD95 , APO - 1 ) , mediator of an apoptotic pathway crucial to lymphocyte homeostasis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Of 17 unique APT1 mutations in unrelated ALPS probands , 12 ( 71 % ) occurred in exons 7 - 9 , which encode the intracellular portion of Fas .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In vitro , activated lymphocytes from all 17 patients showed apoptotic defects when exposed to an anti - Fas agonist monoclonal antibody .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Similar defects were found in a Fas - negative cell line transfected with cDNAs bearing each of the mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In cotransfection experiments , Fas constructs with either intra - or extracellular mutations caused dominant inhibition of apoptosis mediated by wild - type Fas .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Two missense Fas variants , not restricted to patients with ALPS , were identified .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Variant A ( - 1 ) T at the Fas signal - sequence cleavage site , which mediates apoptosis less well than wild - type Fas and is partially inhibitory , was present in 13 % of African American alleles .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Among the ALPS - associated Fas mutants , dominant inhibition of apoptosis was much more pronounced in mutants affecting the intracellular , versus extracellular , portion of the Fas receptor .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutations causing disruption of the intracellular Fas death domain also showed a higher penetrance of ALPS phenotype features in mutation - bearing relatives .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Significant ALPS - related morbidity occurred in 44 % of relatives with intracellular mutations , versus 0 % of relatives with extracellular mutations .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Thus , the location of mutations within APT1 strongly influences the development and the severity of ALPS .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Multicentric origin of hemochromatosis gene ( HFE ) mutations .',\n",
       "  'entities': ['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Genetic hemochromatosis ( GH ) is believed to be a disease restricted to those of European ancestry .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In northwestern Europe , > 80 % of GH patients are homozygous for one mutation , the substitution of tyrosine for cysteine at position 282 ( C282Y ) in the unprocessed protein .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In a proportion of GH patients , two mutations are present , C282Y and H63D .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The clinical significance of this second mutation is such that it appears to predispose 1 % - 2 % of compound heterozygotes to expression of the disease .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The distribution of the two mutations differ , C282Y being limited to those of northwestern European ancestry and H63D being found at allele frequencies > 5 % , in Europe , in countries bordering the Mediterranean , in the Middle East , and in the Indian subcontinent .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The C282Y mutation occurs on a haplotype that extends < / = 6 Mb , suggesting that this mutation has arisen during the past 2 , 000 years .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The H63D mutation is older and does not occur on such a large extended haplotype , the haplotype in this case extending < / = 700 kb .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Here we report the finding of the H63D and C282Y mutations on new haplotypes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In Sri Lanka we have found H63D on three new haplotypes and have found C282Y on one new haplotype , demonstrating that these mutations have arisen independently on this island .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These results suggest that the HFE gene has been the subject of selection pressure .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These selection pressures could be due to infectious diseases , environmental conditions , or other genetic disorders such as anemia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have retrospectively analyzed 837 random anonymized dried blood spot ( DBS ) samples from neonatal screening programs in Scandinavia for mutations in HFE , the candidate gene for hemochromatosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'We have found C282Y allele frequencies of 2 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '3 % ( + 2 . 0 % ) ( - 1 . 3 % ) in Greenland , 4 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '5 % + / - 1 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '9 % in Iceland , 5 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '1 % + / - 2 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '3 % in the Faeroe Islands , and 8 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '2 % + / - 2 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '7 % in Denmark .', 'entities': ['O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The high prevalence of HFE mutations in Denmark suggests that population screening for the C282Y mutation could be highly advantageous in terms of preventive health care .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Long - term follow - up evaluation of C282Y homozygotes and H63D / C282Y compound heterozygotes will give an indication of the penetrance of the mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Identification of the mutation in the alkaptonuria mouse model .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O', 'O']},\n",
       " {'sentence': 'Alkaptonuria ( aku ) , an inborn error of metabolism caused by the loss of homogentisate 1 , 2 - dioxygenase ( HGD ) , has been described in a mouse model created by ethylnitrosourea mutagenesis but the mutation in these mice has not previously been identified .',\n",
       "  'entities': ['B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We used RT - PCR to amplify the Hgd cDNA from Hgd ( aku ) / Hgd ( aku ) mice .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Two products shorter than the wild - type product were amplified .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Restriction mapping and DNA sequencing were then used to identify the Hgd ( aku ) mouse mutation , found to be a single base change in a splice donor consensus sequence , causing exon skipping and frame - shifted products .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This base change allowed us to create a non - radioactive genotyping assay for this allele .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Non - syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Enlarged vestibular aqueduct ( EVA ) , known as the most common form of inner ear abnormality , has recently been of particular genetic interest because this anomaly is inherited in a recessive manner .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The locus for non - syndromic sensorineural hearing loss with EVA has been mapped to the same chromosomal region , 7q31 , as the Pendred syndrome locus .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In the present study , seven mutations in the PDS gene ( PDS ) , the gene responsible for Pendred syndrome , have been found in families of non - syndromic sensorineural hearing loss with EVA .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'One family is homozygous , three families are compound heterozygotes , and two families are heterozygous but with no other mutation detected .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The present results provide evidence that mutations in PDS cause both syndromic and non - syndromic hearing loss . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutational analysis and genotype - phenotype correlation of 29 unrelated Japanese patients with X - linked adrenoleukodystrophy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'BACKGROUND X - linked adrenoleukodystrophy ( ALD ) is an inherited disease characterized by progressive neurologic dysfunction , occasionally associated with adrenal insufficiency .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The classic form of ALD usually has onset in childhood ( childhood cerebral ALD ) , with rapid neurologic deterioration leading to a vegetative state .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Adult - onset cerebral ALD also presents with rapidly progressive neurologic dysfunction .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Milder phenotypes such as adrenomyeloneuropathy and Addison disease only also have been recognized .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Despite discovery of the causative gene , a molecular basis for the diverse clinical presentations remains to be elucidated .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'OBJECTIVES To conduct mutational analyses in 29 Japanese patients with ALD from 29 unrelated families , to obtain knowledge of the spectrum of mutations in this gene , and to study genotype - phenotype correlations in Japanese patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'METHODS The 29 patients comprised 13 patients with childhood cerebral ALD , 11 patients with adult - onset cerebral ALD , and 5 patients with adrenomyeloneuropathy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'We conducted detailed mutational analyses of 29 unrelated Japanese patients with ALD by genomic Southern blot analysis and direct nucleotide sequence analysis of reverse transcriptase - polymerase chain reaction products derived from total RNA that was extracted from cultured skin fibroblasts , lymphoblastoid cells , or peripheral blood leukocytes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'RESULTS Three patients with adult - onset cerebral ALD were identified as having large genomic rearrangements .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The remaining 26 patients were identified as having 21 independent mutations , including 12 novel mutations resulting in small nucleotide alterations in the ALD gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Eighteen ( 69 % ) of 26 mutations were missense mutations .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Most missense mutations involved amino acids conserved in homologous gene products , including PMP70 , mALDRP , and Pxa1p .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The AG dinucleotide deletion at position 1081 - 1082 , which has been reported previously to be the most common mutation in white patients ( 12 % - 17 % ) , was also identified as the most common mutation in Japanese patients ( 12 % ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'All phenotypes were associated with mutations resulting in protein truncation or subtle amino acid changes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'There were no differences in phenotypic expressions between missense mutations involving conserved amino acids and those involving nonconserved amino acids .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'CONCLUSIONS There are no obvious correlations between the phenotypes of patients with ALD and their genotypes , suggesting that other genetic or environmental factors modify the phenotypic expressions of ALD . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A common human skin tumour is caused by activating mutations in beta - catenin .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'WNT signalling orchestrates a number of developmental programs .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'In response to this stimulus , cytoplasmic beta - catenin ( encoded by CTNNB1 ) is stabilized , enabling downstream transcriptional activation by members of the LEF / TCF family .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'One of the target genes for beta - catenin / TCF encodes c - MYC , explaining why constitutive activation of the WNT pathway can lead to cancer , particularly in the colon .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Most colon cancers arise from mutations in the gene encoding adenomatous polyposis coli ( APC ) , a protein required for ubiquitin - mediated degradation of beta - catenin , but a small percentage of colon and some other cancers harbour beta - catenin - stabilizing mutations .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Recently , we discovered that transgenic mice expressing an activated beta - catenin are predisposed to developing skin tumours resembling pilomatricomas .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Given that the skin of these adult mice also exhibits signs of de novo hair - follicle morphogenesis , we wondered whether human pilomatricomas might originate from hair matrix cells and whether they might possess beta - catenin - stabilizing mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Here , we explore the cell origin and aetiology of this common human skin tumour .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'We found nuclear LEF - 1 in the dividing tumour cells , providing biochemical evidence that pilomatricomas are derived from hair matrix cells .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'At least 75 % of these tumours possess mutations affecting the amino - terminal segment , normally involved in phosphorylation - dependent , ubiquitin - mediated degradation of the protein .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This percentage of CTNNB1 mutations is greater than in all other human tumours examined thus far , and directly implicates beta - catenin / LEF misregulation as the major cause of hair matrix cell tumorigenesis in humans . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The Pendred syndrome gene encodes a chloride - iodide transport protein .',\n",
       "  'entities': ['O', 'B', 'I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Pendred syndrome is the most common form of syndromic deafness and characterized by congenital sensorineural hearing loss and goitre .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'This disorder was mapped to chromosome 7 and the gene causing Pendred syndrome ( PDS ) was subsequently identified by positional cloning .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'PDS encodes a putative transmembrane protein designated pendrin .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Pendrin is closely related to a family of sulfate transport proteins that includes the rat sulfate - anion transporter ( encoded by Sat - 1 ; 29 % amino acid sequence identity ) , the human diastrophic dysplasia sulfate transporter ( encoded by DTD ; 32 % ) and the human sulfate transporter downregulated in adenoma ( encoded by DRA ; 45 % ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'On the basis of this homology and the presence of a slightly modified sulfate - transporter signature sequence comprising its putative second transmembrane domain , pendrin has been proposed to function as a sulfate transporter .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We were unable to detect evidence of sulfate transport following the expression of pendrin in Xenopus laevis oocytes by microinjection of PDS cRNA or in Sf9 cells following infection with PDS - recombinant baculovirus .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The rates of transport for iodide and chloride were significantly increased following the expression of pendrin in both cell systems .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our results demonstrate that pendrin functions as a transporter of chloride and iodide , but not sulfate , and may provide insight into thyroid physiology and the pathophysiology of Pendred syndrome . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'HFE mutations analysis in 711 hemochromatosis probands : evidence for S65C implication in mild form of hemochromatosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Hereditary hemochromatosis ( HH ) is a common autosomal recessive genetic disorder of iron metabolism .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The HFE candidate gene encoding an HLA class I - like protein involved in HH was identified in 1996 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Two missense mutations have been described C282Y , accounting for 80 % to 90 % of HH chromosomes , and H63D , which is associated with a milder form of the disease representing 40 % to 70 % of non - C282Y HH chromosomes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We report here on the analysis of C282Y , H63D , and the 193A - - > T substitution leading to the S65C missense substitution in a large series of probands and controls .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The results confirm that the C282Y substitution was the main mutation involved in hemochromatosis , accounting for 85 % of carrier chromosomes , whereas the H63D substitution represented 39 % of the HH chromosomes that did not carry the C282Y mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In addition , our screening showed that the S65C substitution was significantly enriched in probands with at least one chromosome without an assigned mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This substitution accounted for 7 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '8 % of HH chromosomes that were neither C282Y nor H63D .',\n",
       "  'entities': ['O', 'O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'This enrichment of S65C among HH chromosomes suggests that the S65C substitution is associated with the mild form of hemochromatosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Germline BRCA1 alterations in a population - based series of ovarian cancer cases .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The objective of this study was to provide more accurate frequency estimates of breast cancer susceptibility gene 1 ( BRCA1 ) germline alterations in the ovarian cancer population .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To achieve this , we determined the prevalence of BRCA1 alterations in a population - based series of consecutive ovarian cancer cases .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This is the first population - based ovarian cancer study reporting BRCA1 alterations derived from a comprehensive screen of the entire coding region .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'One hundred and seven ovarian cancer cases were analyzed for BRCA1 alterations using the RNase mismatch cleavage assay followed by direct sequencing .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Two truncating mutations , 962del4 and 3600del11 , were identified .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Both patients had a family history of breast or ovarian cancer .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O']},\n",
       " {'sentence': 'Several novel as well as previously reported uncharacterized variants were also identified , some of which were associated with a family history of cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The frequency distribution of common polymorphisms was determined in the 91 Caucasian cancer cases in this series and 24 sister controls using allele - specific amplification .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The rare form of the Q356R polymorphism was significantly ( P = 0 . 03 ) associated with a family history of ovarian cancer , suggesting that this polymorphism may influence ovarian cancer risk .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In summary , our data suggest a role for some uncharacterized variants and rare forms of polymorphisms in determining ovarian cancer risk , and highlight the necessity to screen for missense alterations as well as truncating mutations in this population .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Adrenoleukodystrophy - related protein can compensate functionally for adrenoleukodystrophy protein deficiency ( X - ALD ) : implications for therapy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Inherited defects in the peroxisomal ATP - binding cassette ( ABC ) transporter adrenoleukodystrophy protein ( ALDP ) lead to the lethal peroxisomal disorder X - linked adrenoleukodystrophy ( X - ALD ) , for which no efficient treatment has been established so far .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Three other peroxisomal ABC transporters currently are known adrenoleukodystrophy - related protein ( ALDRP ) , 70 kDa peroxisomal membrane protein ( PMP70 ) and PMP70 - related protein .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'By using transient and stable overexpression of human cDNAs encoding ALDP and its closest relative ALDRP , we could restore the impaired peroxisomal beta - oxidation in fibroblasts of X - ALD patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The pathognomonic accumulation of very long chain fatty acids could also be prevented by overexpression of ALDRP in immortalized X - ALD cells .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Immunofluorescence analysis demonstrated that the functional replacement of ALDP by ALDRP was not due to stabilization of the mutated ALDP itself .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Moreover , we were able to restore the peroxisomal beta - oxidation defect in the liver of ALDP - deficient mice by stimulation of ALDRP and PMP70 gene expression through a dietary treatment with the peroxisome proliferator fenofibrate .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These results suggest that a correction of the biochemical defect in X - ALD could be possible by drug - induced overexpression or ectopic expression of ALDRP . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Centrosome amplification and a defective G2 - M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform - deficient cells .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Germline mutations of the Brca1 tumor suppressor gene predispose women to breast and ovarian cancers .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'To study mechanisms underlying BRCA1 - related tumorigenesis , we derived mouse embryonic fibroblast cells carrying a targeted deletion of exon 11 of the Brca1 gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We show that the mutant cells maintain an intact G1 - S cell cycle checkpoint and proliferate poorly .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'However , a defective G2 - M checkpoint in these cells is accompanied by extensive chromosomal abnormalities .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Mutant fibroblasts contain multiple , functional centrosomes , which lead to unequal chromosome segregation , abnormal nuclear division , and aneuploidy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'These data uncover an essential role of BRCA1 in maintaining genetic stability through the regulation of centrosome duplication and the G2 - M checkpoint and provide a molecular basis for the role of BRCA1 in tumorigenesis . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Defective CD95 / APO - 1 / Fas signal complex formation in the human autoimmune lymphoproliferative syndrome , type Ia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Heterozygous mutations in the CD95 ( APO - 1 / Fas ) receptor occur in most individuals with autoimmune lymphoproliferative syndrome ( ALPS ) and dominantly interfere with apoptosis by an unknown mechanism .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We show that local or global alterations in the structure of the cytoplasmic death domain from nine independent ALPS CD95 death - domain mutations result in a failure to bind the FADD / MORT1 signaling protein .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Despite heterozygosity for the abnormal allele , lymphocytes from ALPS patients showed markedly decreased FADD association and a loss of caspase recruitment and activation after CD95 crosslinking .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These data suggest that intracytoplasmic CD95 mutations in ALPS impair apoptosis chiefly by disrupting death - domain interactions with the signaling protein FADD / MORT1 . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Analysis of alkaptonuria ( AKU ) mutations and polymorphisms reveals that the CCC sequence motif is a mutational hot spot in the homogentisate 1 , 2 dioxygenase gene ( HGO ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We recently showed that alkaptonuria ( AKU ) is caused by loss - of - function mutations in the homogentisate 1 , 2 dioxygenase gene ( HGO ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Herein we describe haplotype and mutational analyses of HGO in seven new AKU pedigrees .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These analyses identified two novel single - nucleotide polymorphisms ( INV4 + 31A - - > G and INV11 + 18A - - > G ) and six novel AKU mutations ( INV1 - 1G - - > A , W60G , Y62C , A122D , P230T , and D291E ) , which further illustrates the remarkable allelic heterogeneity found in AKU .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Reexamination of all 29 mutations and polymorphisms thus far described in HGO shows that these nucleotide changes are not randomly distributed ; the CCC sequence motif and its inverted complement , GGG , are preferentially mutated .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These analyses also demonstrated that the nucleotide substitutions in HGO do not involve CpG dinucleotides , which illustrates important differences between HGO and other genes for the occurrence of mutation at specific short - sequence motifs .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Because the CCC sequence motifs comprise a significant proportion ( 34 . 5 % ) of all mutated bases that have been observed in HGO , we conclude that the CCC triplet is a mutational hot spot in HGO .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Fabry disease : identification of novel alpha - galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Fabry disease ( FD ) ( angiokeratoma corporis diffusum ) is an X - linked inborn error of glycosphingolipid metabolism caused by defects in the lysosomal alpha - galactosidase A gene ( GLA ) .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The enzymatic defect leads to the systemic accumulation of neutral glycosphingolipids with terminal alpha - galactosyl moieties .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Clinically , affected hemizygous males have angiokeratoma , severe acroparesthesia , renal failure , and vasculopathy of the heart and brain .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'While demonstration of alpha - galactosidase deficiency in leukocytes is diagnostic in affected males , enzymatic detection of female carriers is often inconclusive , due to random X - chromosomal inactivation , underlining the need of molecular investigations for accurate genetic counseling .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'By use of chemical cleavage of mismatches adapted to fluorescence - based detection systems , we have characterized the mutations underlying alpha - Gal A deficiency in 16 individuals from six unrelated families with FD .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The mutational spectrum included five missense mutations ( C202W , C223G , N224D , R301Q , and Q327K ) and one splice - site mutation [ IVS3 G ( - 1 ) - - > C ] .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Studies at the mRNA level showed that the latter led to altered pre - mRNA splicing with consequent alteration of the mRNA translational reading frame and generation of a premature termination codon of translation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'By use of this strategy , carrier status was accurately assessed in all seven at - risk females tested , whereas enzymatic dosages failed to diagnose or exclude heterozygosity . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Prenatal diagnosis by FISH in a family with Pelizaeus - Merzbacher disease caused by duplication of PLP gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A diagnosis of Pelizaeus - Merzbacher disease ( MIM 312080 ) was made in a young boy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'No mutation in the coding region of the proteolipid protein ( PLP ) gene had been found .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The boys maternal aunt came for prenatal diagnosis when 16 + weeks pregnant and carrying a male fetus .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Samples were tested for duplication of the PLP gene , by interphase FISH , in lymphocyte preparations from the proband , his aunt and an amniotic fluid cell preparation from the fetus .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The proband was found to carry the duplication , thus confirming the diagnosis of Pelizaeus Merzbacher disease , but neither the aunt nor the fetus carried a duplication . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Dominant negative effect of the APC1309 mutation : a possible explanation for genotype - phenotype correlations in familial adenomatous polyposis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Inactivation of the adenomatous polyposis coli ( APC ) gene product initiates colorectal tumorigenesis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Patients with familial APC ( FAP ) carry germ - line mutations in the APC gene and develop multiple colorectal adenomas and subsequent carcinomas early in life .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The severity of the disease correlates with the position of the inherited APC mutation ( genotype - phenotype correlation ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Together with the fact that both germ - line and sporadic APC mutations cluster in the central region of the APC gene , this points to a dominant negative effect of certain APC mutants .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Loss of APC function was recently shown to result in enhanced beta - catenin - / Tcf - mediated transcription in colon epithelial cells .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Here , we provide experimental evidence for a dominant negative effect of APC gene products associated with severe polyposis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Wild - type APC activity in beta - catenin - / Tcf - mediated transcription was strongly inhibited by a mutant APC that is truncated at codon 1309 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In contrast , mutant APC gene products that are associated with attenuated polyposis ( codon 386 or 1465 ) interfered only weakly with wild - type APC activity .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These results suggest a molecular explanation for the genotype - phenotype correlation in FAP patients and support the idea that colorectal tumor growth might be , in part , driven by selection for a mutation in the mutation cluster region . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'BRCA1 interacts with components of the histone deacetylase complex .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Germ - line mutations in the BRCA1 tumor - suppressor gene are associated with an increased susceptibility to breast and ovarian cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'BRCA1 contains a carboxyl - terminal domain ( BRCT ) that is shared with several other proteins involved in maintaining genome integrity .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In an effort to understand the function of BRCA1 , we sought to isolate proteins that interact with the BRCT domain .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Purified BRCT polypeptide was used as a probe to screen a human placenta cDNA expression library by Far Western analysis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Here we report that BRCA1 interacts in vivo and in vitro with the Rb - binding proteins , RbAp46 and RbAp48 , as well as with Rb .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Moreover , the BRCT domain associates with the histone deacetylases HDAC1 and HDAC2 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These results demonstrate that BRCA1 interacts with components of the histone deacetylase complex , and therefore may explain the involvement of BRCA1 in multiple processes such as transcription , DNA repair , and recombination . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Combined genetic deficiency of C6 and C7 in man .',\n",
       "  'entities': ['B', 'I', 'I', 'I', 'I', 'I', 'I', 'O', 'O', 'O']},\n",
       " {'sentence': 'By routine screening of sera , a subject was discovered who showed a sub - total deficiency of C6 and C7 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'No clinical disease was associated with this deficiency which was transmitted through the subjects family as a single genetic characteristic , the C6 deficiency being associated with a silent allele at the structural locus .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The propositus was found to have low quantities of an abnormal C6 which was both antigenically deficient and smaller in size than normal C6 ( 110 , 000 daltons compared with 140 , 000 daltons ) and small quantities of apparently normal C7 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'It is concluded that the most likely explanation for this defect is that the subject has a structural mutation in his C6 gene which produces hyopsynthesis not only of C6 but also of the closely linked gene for C7 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These findings suggest the possibility that C6 and C7 may function as a single genetic unit and that the primary transcript copied from the genome includes information for both proteins . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Changes at P183 of emerin weaken its protein - protein interactions resulting in X - linked Emery - Dreifuss muscular dystrophy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Emery - Dreifuss muscular dystrophy ( EDMD ) is an X - linked recessive muscular dystrophy characterized by early contractures of the elbows , Achilles tendons and spine , slowly progressive muscle wasting and weakness , and cardiomyopathy associated with cardiac conduction defects .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The emerin gene has been mapped to Xq28 and encodes a 34 - kDa serine - rich protein , emerin , which has been localized to the nuclear envelope in a wide variety of tissues , including skeletal and cardiac muscle .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutations spanning the emerin gene have been identified in patients with EDMD .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'We present here the effect , on emerin protein expression , of two missense mutations identified in unrelated EDMD patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These alterations predict the replacement of a proline residue at position 183 with either a histidine or a threonine .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Biochemical analysis has demonstrated that the mobility and expression levels of the mutant forms of emerin are indistinguishable from that of wild - type emerin , but that they have weakened interactions with nuclear lamina components .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In comparison with the usual EDMD phenotype , patients with P183 missense mutations have a later age at onset of first symptoms , elbow contractures , ankle contractures , upper limb weakness and lower limb weakness , but there is no difference for the age at onset of cardiac involvement .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'This is the first report of protein studies on patients with missense mutations resulting in the clinical features of EDMD .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'These studies demonstrate the importance of proline 183 for the proper structure / function of emerin . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Microdeletions at chromosome bands 1q32 - q41 as a cause of Van der Woude syndrome .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Van der Woude syndrome ( VWS ) is an autosomal dominant disorder comprising cleft lip and / or cleft palate and lip pits .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'We reported previously a family whose underlying mutation is a 500 - 800 kb deletion localized to chromosome bands 1q32 - q41 [ Sander et al . , 1994 Hum Mol Genet 3 576 - 578 ] .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Along with cleft lip / palate and lip pits , affected relatives exhibit developmental delays , suggesting that the function of a gene nearby may also be disrupted .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To further localize the VWS gene we searched for other deletions that cause VWS .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'An allele loss assay was performed using a novel highly polymorphic marker , D1S3753 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'From a panel of 37 unrelated individuals , we detected an allele loss in one family , indicating the presence of a deletion .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In this family , the phenotype in three generations of affected individuals was confined to the cardinal signs of VWS .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Surprisingly , mapping of the new deletion showed that it extended 0 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '2 - 1 Mb beyond the proximal breakpoint for the deletion described previously .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'No deletions were detected in seven cases of popliteal pterygia syndrome , 76 cases of mixed syndromic forms of cleft lip and palate , and 178 cases of nonsyndromic cleft lip and palate .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Splicing defects in the ataxia - telangiectasia gene , ATM : underlying mutations and consequences .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutations resulting in defective splicing constitute a significant proportion ( 30 / 62 [ 48 % ] ) of a new series of mutations in the ATM gene in patients with ataxia - telangiectasia ( AT ) that were detected by the protein - truncation assay followed by sequence analysis of genomic DNA .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Fewer than half of the splicing mutations involved the canonical AG splice - acceptor site or GT splice - donor site .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A higher percentage of mutations occurred at less stringently conserved sites , including silent mutations of the last nucleotide of exons , mutations in nucleotides other than the conserved AG and GT in the consensus splice sites , and creation of splice - acceptor or splice - donor sites in either introns or exons .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These splicing mutations led to a variety of consequences , including exon skipping and , to a lesser degree , intron retention , activation of cryptic splice sites , or creation of new splice sites .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In addition , 5 of 12 nonsense mutations and 1 missense mutation were associated with deletion in the cDNA of the exons in which the mutations occurred .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'No ATM protein was detected by western blotting in any AT cell line in which splicing mutations were identified .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Several cases of exon skipping in both normal controls and patients for whom no underlying defect could be found in genomic DNA were also observed , suggesting caution in the interpretation of exon deletions observed in ATM cDNA when there is no accompanying identification of genomic mutations . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Alpha - cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'We identified the alpha - cardiac actin gene ( ACTC ) as a novel disease gene in a pedigree suffering from familial hypertrophic cardiomyopathy ( FHC ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Linkage analyses excluded all the previously reported FHC loci as possible disease loci in the family studied , with lod scores varying between - 2 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '5 and - 6 .', 'entities': ['O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '0 0 .', 'entities': ['O', 'O', 'O']},\n",
       " {'sentence': 'Further linkage analyses of plausible candidate genes highly expressed in the adult human heart identified ACTC as the most likely disease gene , showing a maximal lod score of 3 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '6 6 .', 'entities': ['O', 'O', 'O']},\n",
       " {'sentence': 'Mutation analysis of ACTC revealed an Ala295Ser mutation in exon 5 close to 2 missense mutations recently described to cause the inherited form of idiopathic dilated cardiomyopathy ( IDC ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Overgrowth of oral mucosa and facial skin , a novel feature of aspartylglucosaminuria .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Aspartylglucosaminuria ( AGU ) is a lysosomal storage disorder caused by deficiency of aspartylglucosaminidase ( AGA ) .',\n",
       "  'entities': ['B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The main symptom is progressive mental retardation .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']},\n",
       " {'sentence': 'A spectrum of different mutations has been reported in this disease , one missense mutation ( Cys163Ser ) being responsible for the majority of Finnish cases .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We were able to examine 66 Finnish AGU patients for changes in the oral mucosa and 44 of these for changes in facial skin .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Biopsy specimens of 16 oral lesions , 12 of them associated with the teeth , plus two facial lesions were studied histologically .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Immunohistochemical staining for AGA was performed on 15 oral specimens .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Skin was seborrhoeic in adolescent and adult patients , with erythema of the facial skin already common in childhood .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Of 44 patients , nine ( 20 % ) had facial angiofibromas , tumours primarily occurring in association with tuberous sclerosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Oedemic buccal mucosa ( leucoedema ) and gingival overgrowths were more frequent in AGU patients than in controls ( p < 0 . 001 ) .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Of 16 oral mucosal lesions studied histologically , 15 represented fibroepithelial or epithelial hyperplasias and were reactive in nature .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Cytoplasmic vacuolisation was evident in four .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Immunohistochemically , expression of AGA in AGU patients mucosal lesions did not differ from that seen in corresponding lesions of normal subjects .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Thus , the high frequency of mucosal overgrowth in AGU patients does not appear to be directly associated with lysosomal storage or with alterations in the level of AGA expression .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Characterization of a germline mosaicism in families with Lowe syndrome , and identification of seven novel mutations in the OCRL1 gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The oculocerebrorenal syndrome of Lowe ( OCRL ) is an X - linked disorder characterized by major abnormalities of eyes , nervous system , and kidneys .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Mutations in the OCRL1 gene have been associated with the disease .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'OCRL1 encodes a phosphatidylinositol 4 , 5 - biphosphate ( PtdIns [ 4 , 5 ] P2 ) 5 - phosphatase .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have examined the OCRL1 gene in eight unrelated patients with OCRL and have found seven new mutations and one recurrent in - frame deletion .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Among the new mutations , two nonsense mutations ( R317X and E558X ) and three other frameshift mutations caused premature termination of the protein .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A missense mutation , R483G , was located in the highly conserved PtdIns ( 4 , 5 ) P2 5 - phosphatase domain .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Finally , one frameshift mutation , 2799delC , modifies the C - terminal part of OCRL1 , with an extension of six amino acids .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Altogether , 70 % of missense mutations are located in exon 15 , and 52 % of all mutations cluster in exons 11 - 15 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We also identified two new microsatellite markers for the OCRL1 locus , and we detected a germline mosaicism in one family .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This observation has direct implications for genetic counseling of Lowe syndrome families . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'MEFV - Gene analysis in armenian patients with Familial Mediterranean fever : diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype - genetic and therapeutic implications .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Familial Mediterranean fever ( FMF ) is a recessively inherited disorder that is common in patients of Armenian ancestry .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To date , its diagnosis , which can be made only retrospectively , is one of exclusion , based entirely on nonspecific clinical signs that result from serosal inflammation and that may lead to unnecessary surgery .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Renal amyloidosis , prevented by colchicine , is the most severe complication of FMF , a disorder associated with mutations in the MEFV gene .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To evaluate the diagnostic and prognostic value of MEFV - gene analysis , we investigated 90 Armenian FMF patients from 77 unrelated families that were not selected through genetic - linkage analysis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Eight mutations , one of which ( R408Q ) is new , were found to account for 93 % of the 163 independent FMF alleles , with both FMF alleles identified in 89 % of the patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In several instances , family studies provided molecular evidence for pseudodominant transmission and incomplete penetrance of the disease phenotype .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The M694V homozygous genotype was found to be associated with a higher prevalence of renal amyloidosis and arthritis , compared with other genotypes ( P = . 0002 and P = . 006 , respectively ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The demonstration of both the diagnostic and prognostic value of MEFV analysis and particular modes of inheritance should lead to new ways for management of FMF - including genetic counseling and therapeutic decisions in affected families .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Noninvasive test for fragile X syndrome , using hair root analysis .',\n",
       "  'entities': ['O', 'O', 'O', 'B', 'I', 'I', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Identification of the FMR1 gene and the repeat - amplification mechanism causing fragile X syndrome led to development of reliable DNA - based diagnostic methods , including Southern blot hybridization and PCR .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Both methods are performed on DNA isolated from peripheral blood cells and measure the repeat size in FMR1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Using an immunocytochemical technique on blood smears , we recently developed a novel test for identification of patients with fragile X syndrome .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'This method , also called \" antibody test , \" uses monoclonal antibodies against the FMR1 gene product ( FMRP ) and is based on absence of FMRP in patients cells .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Here we describe a new diagnostic test to identify male patients with fragile X syndrome , on the basis of lack of FMRP in their hair roots .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Expression of FMRP in hair roots was studied by use of an FMRP - specific antibody test , and the percentage of FMRP - expressing hair roots in controls and in male fragile X patients was determined .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Control individuals showed clear expression of FMRP in nearly every hair root , whereas male fragile X patients lacked expression of FMRP in almost all their hair roots .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mentally retarded female patients with a full mutation showed FMRP expression in only some of their hair roots ( < 55 % ) , and no overlap with normal female controls was observed .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The advantages of this test are ( 1 ) plucking of hair follicles does no appreciable harm to the mentally retarded patient , ( 2 ) hairs can be sent in a simple envelope to a diagnostic center , and ( 3 ) the result of the test is available within 5 h of plucking .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In addition , this test enabled us to identify two fragile X patients who did not show the full mutation by analysis of DNA isolated from blood cells . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In Swedish families with hereditary prostate cancer , linkage to the HPC1 locus on chromosome 1q24 - 25 is restricted to families with early - onset prostate cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Prostate cancer clusters in some families , and an estimated 5 % - 10 % of all cases are estimated to result from inheritance of prostate cancer - susceptibility genes .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We previously reported evidence of linkage to the 1q24 - 25 region ( HPC1 ) in 91 North American and Swedish families each with multiple cases of prostate cancer ( Smith et al . 1996 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In the present report we analyze 40 ( 12 original and 28 newly identified ) Swedish families with hereditary prostate cancer ( HPC ) that , on the basis of 40 markers spanning a 25 - cM interval within 1q24 - 25 , have evidence of linkage .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In the complete set of families , a maximum two - point LOD score of 1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '10 was observed at D1S413 ( at a recombination fraction [ theta ] of . 1 ) , with a maximum NPL ( nonparametric linkage ) Z score of 1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '64 at D1S202 ( P = . 05 ) .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The evidence of linkage to this region originated almost exclusively from the subset of 12 early - onset ( age < 65 years ) families , which yielded a maximum LOD score of 2 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '38 at D1S413 ( straight theta = 0 ) and an NPL Z score of 1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '95 at D1S422 ( P = . 03 ) .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Estimates from heterogeneity tests suggest that , within Sweden , as many as 50 % of early - onset families had evidence of linkage to the HPC1 region .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These results are consistent with the hypothesis of linkage to HPC1 in a subset of families with prostate cancer , particularly those with an early age at diagnosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Molecular basis of feline beta - glucuronidase deficiency : an animal model of mucopolysaccharidosis VII .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'A family of domestic cats was found that exhibited clinical and biochemical abnormalities consistent with mucopolysaccharidosis VII , an autosomal recessive lysosomal storage disorder caused by beta - glucuronidase deficiency .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'beta - Glucuronidase activity was undetectable in affected cat fibroblasts and restored by retroviral gene transfer of rat beta - glucuronidase cDNA .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'beta - Glucuronidase mRNA was normal in affected cat testis by Northern blot analysis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Normal feline beta - glucuronidase cDNA was cloned and characterized , and amplified from affected cat fibroblasts by reverse transcription coupled polymerase chain reaction .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'There was a G - to - A transition in the affected cat cDNA that predicted an E351K substitution , destroyed a BssSI site , and eliminated GUSB enzymatic activity in expression studies .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Multiple species comparison and the crystal structure of human beta - glucuronidase indicated that E351 is a highly conserved residue most likely essential in maintenance of the enzymes conformation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'BssSI digestion of polymerase chain reaction products amplified from genomic DNA indicated that affected cats were homozygous and cats with half - normal beta - glucuronidase activity were heterozygous for the missense mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Carriers identified in this manner produced affected kittens in prospective breedings , and a feline MPS VII breeding colony has been established . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A common molecular basis for rearrangement disorders on chromosome 22q11 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The chromosome 22q11 region is susceptible to rearrangements that are associated with congenital anomaly disorders and malignant tumors .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Three congenital anomaly disorders , cat - eye syndrome , der ( ) syndrome and velo - cardio - facial syndrome / DiGeorge syndrome ( VCFS / DGS ) are associated with tetrasomy , trisomy or monosomy , respectively , for part of chromosome 22q11 .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'VCFS / DGS is the most common syndrome associated with 22q11 rearrangements .',\n",
       "  'entities': ['B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In order to determine whether there are particular regions on 22q11 that are prone to rearrangements , the deletion end - points in a large number of VCFS / DGS patients were defined by haplotype analysis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Most VCFS / DGS patients have a similar 3 Mb deletion , some have a nested distal deletion breakpoint resulting in a 1 .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '5 Mb deletion and a few rare patients have unique deletions or translocations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The high prevalence of the disorder in the population and the fact that most cases occur sporadically suggest that sequences at or near the breakpoints confer susceptibility to chromosome rearrangements .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To investigate this hypothesis , we developed hamster - human somatic hybrid cell lines from VCFS / DGS patients with all three classes of deletions and we now show that the breakpoints occur within similar low copy repeats , termed LCR22s .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To support this idea further , we identified a family that carries an interstitial duplication of the same 3 Mb region that is deleted in VCFS / DGS patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We present models to explain how the LCR22s can mediate different homologous recombination events , thereby generating a number of rearrangements that are associated with congenital anomaly disorders .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'We identified five additional copies of the LCR22 on 22q11 that may mediate other rearrangements leading to disease .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Functional consequences of mutations in the early growth response 2 gene ( EGR2 ) correlate with severity of human myelinopathies .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The early growth response 2 gene ( EGR2 ) is a Cys2His2zinc finger transcription factor which is thought to play a role in the regulation of peripheral nervous system myelination .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This idea is based partly on the phenotype of homozygous Krox20 ( Egr2 ) knockout mice , which display hypomyelination of the PNS and a block of Schwann cells at an early stage of differentiation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutations in the human EGR2 gene have recently been associated with the inherited peripheral neuropathies Charcot - Marie - Tooth type 1 , Dejerine - Sottas syndrome and congenital hypomyelinating neuropathy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Three of the four EGR2 mutations are dominant and occur within the zinc finger DNA - binding domain .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The fourth mutation is recessive and affects the inhibitory domain ( R1 ) that binds the NAB transcriptional co - repressors .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A combination of DNA - binding assays and transcriptional analysis was used to determine the functional consequences of these mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The zinc finger mutations affect DNA binding and the amount of residual binding directly correlates with disease severity .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The R1 domain mutation prevents interaction of EGR2 with the NAB co - repressors and thereby increases transcriptional activity .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These data provide insight into the possible disease mechanisms underlying EGR2 mutations and the reason for varying severity and differences in inheritance patterns . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post - natal development of arginine vasopressin ( AVP ) deficiency due to mutations in the AVP gene .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'All published mutations affect the signal peptide or the neurophysin - II carrier protein and are presumed to interfere with processing of the preprohormone , leading to neuronal damage .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'We studied an unusual Palestinian family consisting of asymptomatic first cousin parents and three children affected with neurohypophyseal diabetes insipidus , suggesting autosomal recessive inheritance .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'All three affected children were homozygous and the parents heterozygous for a single novel mutation ( C301 - > T ) in exon 1 , replacing Pro7 of mature AVP with Leu ( Leu - AVP ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Leu - AVP was a weak agonist with approximately 30 - fold reduced binding to the human V2 receptor .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Measured by radioimmunoassay with a synthetic Leu - AVP standard , serum Leu - AVP levels were elevated in all three children and further increased during water deprivation to as high as 30 times normal .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The youngest child ( 2 years old ) was only mildly affected but had Leu - AVP levels similar to her severely affected 8 - year - old brother , suggesting that unknown mechanisms may partially compensate for a deficiency of active AVP in very young children . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'X inactivation and somatic cell selection rescue female mice carrying a Piga - null mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A somatic mutation in the X linked PIGA gene is responsible for the deficiency of glycosyl phosphatidylinositol ( GPI ) - anchored proteins on blood cells from patients with paroxysmal nocturnal hemoglobinuria .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'No inherited form of GPI - anchor deficiency has been described .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Because conventional Piga gene knockout is associated with high embryonic lethality in chimeric mice , we used the Cre / loxP system .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We generated mice in which two loxP sites flank part of Piga exon 2 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'After crossbreeding with female mice of the EIIa - cre strain , the floxed allele undergoes Cre - mediated recombination with high efficiency during early embryonic development .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Because of X chromosome inactivation , female offspring are mosaic for cells that express or lack GPI - linked proteins .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Analysis of mosaic mice showed that in heart , lung , kidney , brain , and liver , mainly wild - type Piga is active , suggesting that these tissues require GPI - linked proteins .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The salient exceptions were spleen , thymus , and red blood cells , which had almost equal numbers of cells expressing the wild - type or the recombined allele , implying that GPI - linked proteins are not essential for the derivation of these tissues .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'PIGA ( - ) cells had no growth advantage , suggesting that other factors are needed for their clonal dominance in patients with paroxysmal nocturnal hemoglobinuria . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The C282Y mutation causing hereditary hemochromatosis does not produce a null allele .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Targeted mutagenesis was used to produce two mutations in the murine hemochromatosis gene ( Hfe ) locus .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The first mutation deletes a large portion of the coding sequence , generating a null allele .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The second mutation introduces a missense mutation ( C282Y ) into the Hfe locus , but otherwise leaves the gene intact .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This mutation is identical to the disease - causing mutation in patients with hereditary hemochromatosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Mice carrying each of the two mutations were bred and analyzed .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Homozygosity for either mutation results in postnatal iron loading .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The effects of the null mutation are more severe than the effects of the C282Y mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mice heterozygous for either mutation accumulate more iron than normal controls .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Interestingly , although liver iron stores are greatly increased , splenic iron is decreased .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We conclude that the C282Y mutation does not result in a null allele . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Genotype - phenotype analysis in X - linked Emery - Dreifuss muscular dystrophy and identification of a missense mutation associated with a milder phenotype .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Direct sequencing of the emerin gene in 22 families with Emery - Dreifuss muscular dystrophy ( EMD ) revealed mutations in 21 ( 95 % ) , confirming that emerin mutations can be identified in the majority of families with X - linked EMD .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Most emerin mutations result in absence of the protein .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'In this study three mutations ( a missense mutation Pro183Thr and two in - frame deletions removing residues 95 - 99 and 236 - 241 , respectively ) were unusual in being associated with expression of mutant protein .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The phenotype in these families was compared in detail with the clinical features in cases with typical null mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'For the in - frame deletions there were no significant differences .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'In the family with the missense mutation the phenotype was milder .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Age at onset was later for first symptoms and for development of ankle contractures and muscle weakness .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'These findings have diagnostic implications as well as pointing to functionally important regions of the emerin protein . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Severe clinical expression in X - linked Emery - Dreifuss muscular dystrophy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'X - linked Emery - Dreifuss muscular dystrophy ( EDMD ) is a relatively rare benign neuromuscular disorder which can vary remarkably in onset , course and severity .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In the present study , a TCTAC deletion spanning the nucleotides 631 - 635 of the emerin gene caused an unusually severe disease phenotype including loss of ambulation and severe muscle wasting in two affected brothers .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The same mutation has been reported previously in an unrelated family showing a significantly milder phenotype .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The interfamilial heterogeneity in distribution and in severity of the features in the two families point to environmental or genetic modification as the cause of clinical variability in Emery - Dreifuss muscular dystrophy . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'BACKGROUND Families with a high incidence of hereditary breast cancer , and subsequently shown to have terminating mutations in BRCA1 or BRCA2 , appear to have a higher incidence of prostate cancer among male relatives .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We aimed to determine whether the common germline mutations of BRCA1 or BRCA2 in Ashkenazi Jewish men predisposed them to prostate cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'METHODS We examined genomic DNA from 83 ( for BRCA1 185delAG ) or 82 ( for BRCA2 6174delT ) Ashkenazi Jewish prostate cancer patients , most of whom were treated at a relatively young age , for the most common germline mutation in each gene seen in the Ashkenazi population .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'RESULTS Our study should have been able to detect a 4 - 5 - fold increase in the risk of prostate cancer due to mutation of BRCA1 or BRCA2 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'However , only one ( 1 . 15 % ; 95 % confidence interval , 0 - 3 . 6 % ) of the patients was heterozygous for the BRCA1 mutant allele , and only two were heterozygous for the BRCA2 mutation ( 2 . 4 % ; 95 % confidence interval , 0 - 6 . 2 % ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'CONCLUSIONS The incidence of each of the germline mutations in these prostate cancer patients closely matched their incidence ( about 1 % ) in the general Ashkenazi Jewish population .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This suggests that unlike cases of breast and ovarian cancers , mutations in BRCA1 or BRCA2 do not significantly predispose men to prostate cancer',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I']},\n",
       " {'sentence': 'Beta - catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Hepatoblastoma is a rare malignant tumor of the liver that occurs in children at an average age of 2 to 3 years .',\n",
       "  'entities': ['B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Epidemiologic studies have shown an increased frequency of this tumor type in families affected by adenomatous polyposis coli .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'In addition to the epidemiologic data , molecular genetic studies suggest that inactivation of the APC tumor suppressor may be involved in hepatoblastoma tumorigenesis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A major function of APC is the downregulation of beta - catenin , a transcription - activating protein with oncogenic potential .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In an ongoing immunohistochemical study of beta - catenin expression in sporadic cases of tumor types that are associated with adenomatous polyposis coli , we observed increased beta - catenin levels in the cytoplasm and in the nuclei of three investigated hepatoblastomas .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Sequencing of exon 3 of the beta - catenin gene ( CTNNB1 ) revealed an activating mutation in one of the tumor samples .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our data indicate for the first time that beta - catenin accumulation may play a role in the development of hepatoblastoma and that activating mutations of the beta - catenin gene may substitute biallelic APC inactivation in this tumor type .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Genes Chromosomes Cancer 25 399 - 402 , 1999 . .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Decrease in GTP cyclohydrolase I gene expression caused by inactivation of one allele in hereditary progressive dystonia with marked diurnal fluctuation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Hereditary progressive dystonia with marked diurnal fluctuation ( HPD ; dopa - responsive dystonia , DRD ) have been recently found to be caused by a genetic defect in the GTP cyclohydrolase I ( GCH1 ) gene .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In this study , we quantified the mRNA level of GCH1 in phytohemagglutinin ( PHA ) - stimulated mononuclear blood cells from one Japanese family that do not have a mutation in the coding region or splice junctions of the gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The results showed that the amounts of the GCH1 mRNA were decreased to about 40 % of the normal level in both patients and carriers .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In addition , we found that the GCH1 mRNA was transcribed from only one allele , indicating that the other allele was in an inactive state .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These results suggest that some novel mutations should exist on one of the alleles in some unknown region of the GCH1 gene , and may decrease the GCH1 mRNA causing the HPD / DRD symptoms . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Sulfate transport is not impaired in pendred syndrome thyrocytes .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O', 'O']},\n",
       " {'sentence': 'Pendred syndrome is the most common form of syndromic deafness , characterized by dyshormonogenic goiter associated with sensory - neural deafness .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The gene responsible for the disease ( PDS ) has been cloned , but its function is as yet unknown and the connection between thyroid goiter and sensory - neural deafness remains an enigma .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'PDS codes for a novel protein , pendrin , which is closely related to a number of sufate transporters .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mechanisms by which abnormal sulfate transport could deleteriously affect iodide organification have been proposed .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We tested sulfate transport in thyrocytes obtained from Pendred syndrome patients and found that it was not defective .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This suggests that pendrin in fact may not be a sulfate transporter , and emphasizes the importance of functional studies on this novel protein . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Small deletions in the type II collagen triple helix produce kniest dysplasia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Kniest dysplasia is a moderately severe type II collagenopathy , characterized by short trunk and limbs , kyphoscoliosis , midface hypoplasia , severe myopia , and hearing loss .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Mutations in the gene that encodes type II collagen ( COL2A1 ) , the predominant protein of cartilage , have been identified in a number of individuals with Kniest dysplasia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'All but two of these previously described mutations cause in - frame deletions in type II collagen , either by small deletions in the gene or splice site alterations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Furthermore , all but one of these mutations is located between exons 12 and 24 in the COL2A1 gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We used heteroduplex analysis to identify sequence anomalies in five individuals with Kniest dysplasia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Sequencing of the index patients genomic DNA identified four new dominant mutations in COL2A1 that result in Kniest dysplasia a 21 - bp deletion in exon 16 , an 18 - bp deletion in exon 19 , and 4 - bp deletions in the splice donor sites of introns 14 and 20 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A previously described 28 - bp deletion at the COL2A1 exon 12 - intron 12 junction , deleting the splice donor site , was identified in the fifth case .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The latter three mutations are predicted to result in exon skipping in the mRNA encoded from the mutant allele .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These data suggest that Kniest dysplasia results from shorter type II collagen monomers , and support the hypothesis that alteration of a specific COL2A1 domain , which may span from exons 12 to 24 , leads to the Kniest dysplasia phenotype . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Classical galactosemia and mutations at the galactose - 1 - phosphate uridyl transferase ( GALT ) gene .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Classical galactosemia is caused by a deficiency in activity of the enzyme galactose - 1 - phosphate uridyl transferase ( GALT ) , which , in turn , is caused by mutations at the GALT gene .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The disorder exhibits considerable allelic heterogeneity and , at the end of 1998 , more than 150 different base changes were recorded in 24 different populations and ethnic groups in 15 countries worldwide .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The mutations most frequently cited are Q188R , K285N , S135L , and N314D .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Q188R is the most common mutation in European populations or in those predominantly of European descent .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Overall , it accounts for 60 - 70 % of mutant chromosomes , but there are significant differences in its relative frequency in individual populations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Individuals homoallelic for Q188R tend to have a severe phenotype and this is in keeping with the virtually complete loss of enzyme activity observed in in vitro expression systems .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Globally , K285N is rarer , but in many European populations it can be found on 25 - 40 % of mutant chromosomes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'It is invariably associated with a severe phenotype .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'S135L is found almost exclusively in African Americans .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'In vitro expression results are discrepant , but some individuals carrying S135L appear to exhibit GALT activity in some tissues .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Duarte 1 ( or Los Angeles ) and Duarte 2 ( or Duarte ) variants carry the same amino acid substitution , N314D , even though D1 is associated with increased erythrocyte GALT activity and D2 with reduced activity .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'N314D is in linkage disequilibrium with other base changes that differ on the D1 and D2 alleles .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'N314D does not impair GALT activity in in vitro expression systems .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'However , there are differences in the abundance of GALT protein in lymphoblastoid cells lines from D2 and D1 individuals .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'It is unclear whether the specific molecular changes that distinguish the D1 and D2 alleles account for the different activities .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The considerable genetic heterogeneity documented to date undoubtedly contributes to the phenotypic heterogeneity that is observed in galactosemia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The additional effects of nonallelic variation and other constitutional factors on phenotypic variability remain to be elucidated . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutations of the VHL gene in sporadic renal cell carcinoma : definition of a risk factor for VHL patients to develop an RCC .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'To investigate the nature of somatic von Hippel - Lindau ( VHL ) mutations , we analyzed 173 primary sporadic human renal cell carcinomas for mutations of the VHL tumor suppressor gene , using polymerase chain reaction ( PCR ) and single - strand conformational polymorphism analysis ( SSCP ) of DNA .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We detected abnormal SSCP pattern in 73 samples .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'After sequencing , we identified microdeletions in 58 % of cases , microinsertions in 17 % , nonsense mutations in 8 % , and missense mutations in 17 % .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Among these mutations , 50 % correspond to new mutations .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'VHL mutations were found only in the nonpapillary renal cell carcinoma ( RCC ) subtype , as previously reported .',\n",
       "  'entities': ['B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To compare somatic and germline mutations , we used the VHL database , which includes 507 mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The study of mutational events revealed a significant difference between somatic and germline mutations with mutations leading to truncated proteins observed in 78 % of somatic mutations vs only 37 % in germline mutations ( P < 0 . 001 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We postulated that a specific pattern of VHL mutations is associated with sporadic RCC .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'This pattern corresponds to mutations leading mainly to truncated proteins with few specific missense mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We then analyzed the occurrence of RCC in VHL families , based on the nature of mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We observed RCC in at least one member of the VHL families in 77 % of cases with mutations leading to truncated proteins versus 55 % in cases with missense mutations ( P < 0 . 05 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Thus , mutations resulting in truncated proteins may lead to a higher risk of RCC in VHL patients',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Defective CTLA - 4 cycling pathway in Chediak - Higashi syndrome : a possible mechanism for deregulation of T lymphocyte activation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Cytotoxic T lymphocyte - associated antigen 4 ( CTLA - 4 , also known as CD152 ) has been shown to play a major role in the regulation of T cell activation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Its membrane expression is highly regulated by endocytosis and trafficking through the secretory lysosome pathway .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Chediak - Higashi syndrome ( CHS ) is an inherited disorder caused by mutations in the lysosomal trafficking regulator gene , LYST .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'It results in defective membrane targeting of the proteins present in secretory lysosomes , and it is associated with a variety of features , including a lymphoproliferative syndrome with hemophagocytosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The murine equivalent of CHS , beige mice , present similar characteristics but do not develop the lymphoproliferative syndrome .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'We show herein that CTLA - 4 is present in enlarged , abnormal vesicles in CHS T cells and is not properly expressed at the cell surface after T cell activation , whereas its surface expression is not impaired .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'It is therefore proposed that the defective surface expression of CTLA - 4 by CHS T cells is involved in the generation of lymphoproliferative disease .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'This observation may provide insight into the role of CTLA - 4 in humans . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus - Merzbacher Disease : duplications , the major cause of the disease , originate more frequently in male germ cells , but point mutations do not .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The Clinical European Network on Brain Dysmyelinating Disease .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'O']},\n",
       " {'sentence': 'Pelizaeus - Merzbacher Disease ( PMD ) is an X - linked developmental defect of myelination affecting the central nervous system and segregating with the proteolipoprotein ( PLP ) locus .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Investigating 82 strictly selected sporadic cases of PMD , we found PLP mutations in 77 % ; complete PLP - gene duplications were the most frequent abnormality ( 62 % ) , whereas point mutations in coding or splice - site regions of the gene were involved less frequently ( 38 % ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We analyzed the maternal status of 56 cases to determine the origin of both types of PLP mutation , since this is relevant to genetic counseling .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In the 22 point mutations , 68 % of mothers were heterozygous for the mutation , a value identical to the two - thirds of carrier mothers that would be expected if there were an equal mutation rate in male and female germ cells .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In sharp contrast , among the 34 duplicated cases , 91 % of mothers were carriers , a value significantly ( chi2 = 9 . 20 , P < . 01 ) in favor of a male bias , with an estimation of the male / female mutation frequency ( k ) of 9 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '3 3 .', 'entities': ['O', 'O', 'O']},\n",
       " {'sentence': 'Moreover , we observed the occurrence of de novo mutations between parental and grandparental generations in 17 three - generation families , which allowed a direct estimation of the k value ( k = 11 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Again , a significant male mutation imbalance was observed only for the duplications .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Chromosome breakage in the Prader - Willi and Angelman syndromes involves recombination between large , transcribed repeats at proximal and distal breakpoints .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Prader - Willi syndrome ( PWS ) and Angelman syndrome ( AS ) are distinct neurobehavioral disorders that most often arise from a 4 - Mb deletion of chromosome 15q11 - q13 during paternal or maternal gametogenesis , respectively .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'At a de novo frequency of approximately .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '67 - 1 / 10 , 000 births , these deletions represent a common structural chromosome change in the human genome .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To elucidate the mechanism underlying these events , we characterized the regions that contain two proximal breakpoint clusters and a distal cluster .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Novel DNA sequences potentially associated with the breakpoints were positionally cloned from YACs within or near these regions .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Analyses of rodent - human somatic - cell hybrids , YAC contigs , and FISH of normal or rearranged chromosomes 15 identified duplicated sequences ( the END repeats ) at or near the breakpoints .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The END - repeat units are derived from large genomic duplications of a novel gene ( HERC2 ) , many copies of which are transcriptionally active in germline tissues .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'One of five PWS / AS patients analyzed to date has an identifiable , rearranged HERC2 transcript derived from the deletion event .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We postulate that the END repeats flanking 15q11 - q13 mediate homologous recombination resulting in deletion .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Furthermore , we propose that active transcription of these repeats in male and female germ cells may facilitate the homologous recombination process .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Linkage analysis in a large Brazilian family with van der Woude syndrome suggests the existence of a susceptibility locus for cleft palate at 17p11 . 2 - 11 . 1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'van der Woude syndrome ( VWS ) , which has been mapped to 1q32 - 41 , is characterized by pits and / or sinuses of the lower lip , cleft lip / palate ( CL / P ) , cleft palate ( CP ) , bifid uvula , and hypodontia ( H ) .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The expression of VWS , which has incomplete penetrance , is highly variable .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Both the occurrence of CL / P and CP within the same genealogy and a recurrence risk < 40 % for CP among descendants with VWS have suggested that the development of clefts in this syndrome is influenced by modifying genes at other loci .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To test this hypothesis , we have conducted linkage analysis in a large Brazilian kindred with VWS , considering as affected the individuals with CP , regardless of whether it is associated with other clinical signs of VWS .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Our results suggest that a gene at 17p11 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '2 - 11 2 - 11 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '1 , together with the VWS gene at 1p32 - 41 , enhances the probability of CP in an individual carrying the two at - risk genes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'If this hypothesis is confirmed in other VWS pedigrees , it will represent one of the first examples of a gene , mapped through linkage analysis , which modifies the expression of a major gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'New mutations , polymorphisms , and rare variants in the ATM gene detected by a novel SSCP strategy .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The gene for ataxia - telangiectasia , ATM , spans about 150 kb of genomic DNA .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'ATM mutations are found along the entire gene , with no evidence of a mutational hot spot .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Using DNA as the starting material , we screened the ATM gene in 92 A - T patients , using an optimized single - strand conformation polymorphism ( SSCP ) technique that detected all previously known mutations in the polymerase chain reaction ( PCR ) segments being analyzed .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To expedite screening , we sequentially loaded the SSCP gels with three different sets of PCR products that were pretested to avoid overlapping patterns .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Many of the DNA changes we detected were intragenic polymorphisms .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Of an expected 177 unknown mutations , we detected approximately 70 % , mostly protein truncating mutations ( that would have been detectable by protein truncation testing if RNA starting material had been available ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutations have now been defined for every exon of the ATM gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Herein , we present 35 new mutations and 34 new intragenic polymorphisms or rare variants within the ATM gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This is the most comprehensive compilation of ATM polymorphisms assembled to date .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Defining polymorphic sites as well as mutations in the ATM gene will be of great importance in designing automated methods for detecting mutations . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A novel frameshift mutation in the McLeod syndrome gene in a Japanese family .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We report a novel mutation in the XK gene ( XK ) in a Japanese patient with McLeod syndrome .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'A 50 - year - old man showed progressive muscular atrophy , choreic movement , elevated level of serum creatinine kinase , and acanthocytosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The expression level of all the Kell antigens in erythrocyte was decreased and molecular analysis revealed a single - base ( T ) deletion at the nucleotide position 1095 in XK .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This deletion caused a frameshift in translation , leading to a premature stop codon at the amino acid position 408 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We conclude this single - base deletion causes defective Kx protein , which is responsible for the McLeod phenotype in this patient . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Association of BRCA1 with the hRad50 - hMre11 - p95 complex and the DNA damage response .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'BRCA1 encodes a tumor suppressor that is mutated in familial breast and ovarian cancers .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Here , it is shown that BRCA1 interacts in vitro and in vivo with hRad50 , which forms a complex with hMre11 and p95 / nibrin .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Upon irradiation , BRCA1 was detected in discrete foci in the nucleus , which colocalize with hRad50 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Formation of irradiation - induced foci positive for BRCA1 , hRad50 , hMre11 , or p95 was dramatically reduced in HCC / 1937 breast cancer cells carrying a homozygous mutation in BRCA1 but was restored by transfection of wild - type BRCA1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Ectopic expression of wild - type , but not mutated , BRCA1 in these cells rendered them less sensitive to the DNA damage agent , methyl methanesulfonate .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These data suggest that BRCA1 is important for the cellular responses to DNA damage that are mediated by the hRad50 - hMre11 - p95 complex . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Relationship among genotype , biochemical phenotype , and cognitive performance in females with phenylalanine hydroxylase deficiency : report from the Maternal Phenylketonuria Collaborative Study .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'OBJECTIVE To examine the relationship of phenylalanine hydroxylase ( PAH ) genotypes to biochemical phenotype and cognitive development in maternal phenylketonuria ( PKU ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'METHODOLOGY PAH gene mutations were examined in 222 hyperphenylalaninemic females enrolled in the Maternal PKU Collaborative Study ( MPKUCS ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A total of 84 different mutations were detected , and complete genotype was obtained in 199 individuals .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Based on previous knowledge about mutation - phenotype associations , 78 of the mutations could be assigned to one of four classes of severity ( severe PKU , moderate PKU , mild PKU , and mild hyperphenylalaninemia [ MHP ] ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Then , 189 MPKUCS subjects were grouped according to the various combinations of mutation classifications .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The sample sizes were large enough for statistical testing in four groups with at least one mutation that completely abolishes enzyme activity .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These patients are considered functionally hemizygous .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'RESULTS The biochemical phenotype predicted from the genotype in functionally hemizygous patients was related significantly to the assigned phenylalanine level .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Cognitive performance ( IQ ) was also significantly related to genotype .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The IQ of PAH - deficient mothers with a severe PKU mutation in combination with a MHP mutation or a mild PKU mutation was 99 and 96 , respectively , whereas the IQ of PKU mothers with two severe PKU mutations or with one severe and one moderate PKU mutation was 83 and 84 , respectively .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Of the patients with PKU , 92 % had been treated during childhood .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Those who were untreated or treated late had lower than average IQ scores for their group of mutation combinations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Females with moderate or mild PKU who were treated early and treated for > 6 years showed IQ scores 10 points above average for their group .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'CONCLUSIONS The reproductive outcome in maternal phenylketonuria is dependent on prenatal metabolic control and postnatal environmental circumstances .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Both factors depend on the intellectual resources of the mother with PKU .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The significant relationship among genotype , biochemical phenotype , and cognitive performance observed in the present study is of importance for the development of an optimal strategy for future treatment of females with PKU who plan pregnancy . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Spinal xanthomatosis : a variant of cerebrotendinous xanthomatosis .',\n",
       "  'entities': ['B', 'I', 'O', 'O', 'O', 'O', 'B', 'I', 'O']},\n",
       " {'sentence': 'We describe seven Dutch patients from six families with a slowly progressive , mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis ( CTX ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'MRI demonstrated white matter abnormalities in the lateral and dorsal columns of the spinal cord .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Post - mortem examination of one of the patients showed extensive myelin loss in these columns .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'An array of genotypes was found in these patients .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'We conclude that spinal xanthomatosis is a clinical and radiological separate entity of CTX that should be included in the differential diagnosis of chronic myelopathy . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A transgene insertion creating a heritable chromosome deletion mouse model of Prader - Willi and angelman syndromes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Prader - Willi syndrome ( PWS ) and Angelman syndrome ( AS ) result from the loss of function of imprinted genes in human chromosome 15q11 - q13 .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The central part of mouse chromosome 7 is homologous to human 15q11 - q13 , with conservation of both gene order and imprinted features .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We report here the characterization of a transgene insertion ( Epstein - Barr virus Latent Membrane Protein 2A , LMP2A ) into mouse chromosome 7C , which has resulted in mouse models for PWS and AS dependent on the sex of the transmitting parent .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Epigenotype ( allelic expression and DNA methylation ) and fluorescence in situ hybridization analyses indicate that the transgene - induced mutation has generated a complete deletion of the PWS / AS - homologous region but has not deleted flanking loci .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Because the intact chromosome 7 , opposite the deleted homolog , maintains the correct imprint in somatic cells of PWS and AS mice and establishes the correct imprint in male and female germ cells of AS mice , homologous association and replication asynchrony are not part of the imprinting mechanism .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This heritable - deletion mouse model will be particularly useful for the identification of the etiological genes and mechanisms , phenotypic basis , and investigation of therapeutic approaches for PWS . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32 - q41 markers further supports locus homogeneity of the disease trait .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'van der Woude syndrome ( vWS , MIM 119300 ) is a rare autosomal dominant clefting condition with cardinal features of mucous cysts ( lower - lip pits ) and clefts to the lip and / or palate .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The vWS gene has been assigned to a locus in 1q32 - q41 by linkage analysis and physical mapping .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have investigated 5 novel vWS families through probands attended for cleft lip and / or palate repair at the Department of Maxillofacial Surgery of Hopital Trousseau , Paris , in order to tentatively refine the genetic map of the vWS region in 1q32 - q41 and possibly identify unlinked pedigrees .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Linkage analysis was carried out to 6 microsatellite markers ( D1S249 , D1S425 , D1S491 , D1S205 , D1S414 , D1S425 ) , yielding a maximum cumulative LOD score of Z = 3 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '27 at theta = 0 .', 'entities': ['O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '00 for D1S245 .', 'entities': ['O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The innermost four markers were found to be tightly linked to one another , with no evidence for recombination .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our results support linkage of vWS within a region of tightly linked markers and do not favour locus heterogeneity of the disease trait .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Null mutation of the murine ATP7B ( Wilson disease ) gene results in intracellular copper accumulation and late - onset hepatic nodular transformation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The Atp7b protein is a copper - transporting ATPase expressed predominantly in the liver and to a lesser extent in most other tissues .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutations in the ATP7B gene lead to Wilson disease , a copper toxicity disorder characterized by dramatic build - up of intracellular hepatic copper with subsequent hepatic and neuro - logical abnormalities .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Using homologous recombination to disrupt the normal translation of ATP7B , we have generated a strain of mice that are homozygous mutants ( null ) for the Wilson disease gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The ATP7B null mice display a gradual accumulation of hepatic copper that increases to a level 60 - fold greater than normal by 5 months of age .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'An increase in copper concentration was also observed in the kidney , brain , placenta and lactating mammary glands of homo - zygous mutants , although milk from the mutant glands was copper deficient .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Morphological abnormalities resembling cirrhosis developed in the majority of the livers from homozygous mutants older than 7 months of age .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Progeny of the homozygous mutant females demonstrated neurological abnormalities and growth retardation characteristic of copper deficiency .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Copper concentration in the livers of the newborn homozygous null mutants was decreased dramatically .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In summary , inactivation of the murine ATP7B gene produces a form of cirrhotic liver disease that resembles Wilson disease in humans and the toxic milk phenotype in the mouse . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'French Machado - Joseph disease patients do not exhibit gametic segregation distortion : a sperm typing analysis .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Segregation distortion has been reported to occur in a number of the trinucleotide repeat disorders .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'On the basis of a sperm typing study performed in patients of Japanese descent with Machado - Joseph disease ( MJD ) , it was reported that disease alleles are preferentially transmitted during meiosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We performed a sperm typing study of five MJD patients of French descent and analysis of the pooled data shows a ratio of mutant to normal alleles of 379 436 ( 46 . 5 53 . 5 % ) , which does not support meiotic segregation distortion .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To confirm these results , sperm typing analysis was also performed using a polymorphic marker , D14S1050 , closely linked to the MJD1 gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Among 910 sperm analyzed , the allele linked to the disease chromosome was detected in 50 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '3 % of the samples and the allele linked to the normal chromosome was found in 49 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '6 % of the sperm .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The difference in frequency of these two alleles is not significant ( P = 0 . 8423 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Likelihood - based analysis of segregation distortion in the single sperm data using the SPERMSEG program also showed no support for segregation distortion at the gamete level in this patient population .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The previous report on the Japanese patients also suggested that disease allele stability may be influenced by a trans effect of an intragenic polymorphism ( 987 G / C ) in the wild - type allele .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'All of the French patients were heterozygous for this polymorphism .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'However , analysis of the variance in repeat number in sperm from the French MJD patients overlapped significantly with the variance in repeat number observed in the C / C homozygous Japanese patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Missense mutation in the alternative splice region of the PAX6 gene in eye anomalies .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The PAX6 gene is involved in ocular morphogenesis , and PAX6 mutations have been detected in various types of ocular anomalies , including aniridia , Peters anomaly , corneal dystrophy , congenital cataract , and foveal hypoplasia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The gene encodes a transcriptional regulator that recognizes target genes through its paired - type DNA - binding domain .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The paired domain is composed of two distinct DNA - binding subdomains , the N - terminal subdomain ( NTS ) and the C - terminal subdomain ( CTS ) , which bind respective consensus DNA sequences .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The human PAX6 gene produces two alternative splice isoforms that have the distinct structure of the paired domain .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The insertion , into the NTS , of 14 additional amino acids encoded by exon 5a abolishes the DNA - binding activity of the NTS and unmasks the DNA - binding ability of the CTS .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Thus , exon 5a appears to function as a molecular switch that specifies target genes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We ascertained a novel missense mutation in four pedigrees with Peters anomaly , congenital cataract , Axenfeldt anomaly , and / or foveal hypoplasia , which , to our knowledge , is the first mutation identified in the splice - variant region .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A T - - > A transition at the 20th nucleotide position of exon 5a results in a Val - - > Asp ( GTC - - > GAC ) substitution at the 7th codon of the alternative splice region .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Functional analyses demonstrated that the V54D mutation slightly increased NTS binding and decreased CTS transactivation activity to almost half . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'For genetic counseling and predictive testing in families with inherited breast - ovarian cancer , penetrances and expressions of the underlying mutations should be known .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have previously reported two BRCA1 founder mutations in the Norwegian population .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Index cases for the present study were found two different ways through a series of consecutive ovarian cancers ( n = 16 ) and through our family cancer clinic ( n = 14 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Altogether , 20 of the patients had BRCA1 1675delA , and 10 had 1135insA .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Their relatives were described with respect to absence / presence of breast and / or ovarian cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Of 133 living female relatives , 83 ( 62 % ) were tested for the presence of a mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'No difference , in penetrance and expression , between the two mutations were found , whereas differences according to method of ascertainment were seen .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The overall findings were that disease started to occur at age 30 years and that by age 50 years 48 % of the mutation - carrying women had experienced breast and / or ovarian cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'More ovarian cancers than breast cancers were recorded .',\n",
       "  'entities': ['O', 'B', 'I', 'O', 'B', 'I', 'O', 'O', 'O']},\n",
       " {'sentence': 'Both penetrance and expression ( breast cancer vs . ovarian cancer ) were different from those in reports of the Ashkenazi founder mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Whether the reported differences reflect true differences and / or methodological problems is discussed .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'An observed excess of mutation carriers could not be accounted for by methodological problems ; possible explanations were a \" true \" low penetrance or preferential segregation . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The dermatofibrosarcoma protuberans - associated collagen type Ialpha1 / platelet - derived growth factor ( PDGF ) B - chain fusion gene generates a transforming protein that is processed to functional PDGF - BB .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Dermatofibrosarcoma protuberans ( DFSP ) displays chromosomal rearrangements involving chromosome 17 and 22 , which fuse the collagen type Ialpha1 ( COLIA1 ) gene to the platelet - derived growth factor ( PDGF ) B - chain ( PDGFB ) gene .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To characterize the functional and structural properties of the COLIA1 / PDGFB fusion protein , we generated a stable NIH3T3 cell line that contained a tumor - derived chimeric gene resulting from a COIA1 intron 7 - PDGFB intron 1 fusion .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Expression of the fusion protein led to morphological transformation and increased growth rate of these cells .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The PDGF receptor kinase inhibitor CGP57148B reversed the transformed phenotype and reduced the growth rate of COLIA1 / PDGFB - expressing cells but had no effects on control cells .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The presence of dimeric COLIA1 / PDGFB precursors was demonstrated through PDGFB immunoprecipitations of metabolically labeled cells and also by PDGFB immunoprecipitations followed by immunoblotting with COLIA1 antibodies .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Pulse - chase studies demonstrated that the COLIA1 / PDGFB precursor was processed to an end product that was indistinguishable from wild - type PDGF - BB .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Finally , COLIA1 / PDGFB - expressing cells generated tumors after s .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'c c . injection into nude mice , and tumor growth was reduced by treatment with CGP57148B .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We conclude that the COLIA1 / PDGFB fusion associated with DFSP contributes to tumor development through ectopic production of PDGF - BB and the formation of an autocrine loop .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our findings , thus , suggest that PDGF receptors could be a target for pharmacological treatment of DFSP and giant cell fibroblastoma , e . g . , through the use of PDGF receptor kinase inhibitors such as CGP57148B .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Identification of a common PEX1 mutation in Zellweger syndrome .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'O']},\n",
       " {'sentence': 'The Zellweger spectrum of disease , encompassing Zellweger syndrome and the progressively milder phenotypes of neonatal adrenoleukodystrophy and infantile Refsum disease , is due to a failure to form functional peroxisomes .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Cell fusion complementation studies demonstrated that these diseases are genetically heterogeneous , with two - thirds of all patients lying within a single complementation group , CG1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Molecular genetic and cell biology studies have shown that PEX1 is deficient in many CG1 patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'However , previous studies have focused on mildly affected patients and there is still no report of two mutant PEX1 alleles in any Zellweger syndrome patient .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Furthermore , mutations in the PMP70 gene have also been identified in two Zellweger syndrome patients from CG1 , raising the possibility that CG1 patients may represent a mixture of PEX1 - deficient and PMP70 - deficient individuals .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To address the molecular basis of disease in Zellweger syndrome patients from CG1 , we examined all 24 PEX1 exons in four patients , including both patients that have mutations in PMP70 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'PEX1 mutations were detected in all four patients , including a 1 - bp insertion ( c . 2097insT ) in exon 13 that was present in three of the four patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Subsequent studies demonstrated that this mutation is present in one - half of all CG1 patients and correlates with the Zellweger syndrome phenotype .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'As this mutation leads to a loss of protein function its frequency makes it the most common cause of Zellweger syndrome , helping to explain the high percentage of patients that belong to CG1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Novel mutations in the Wiskott - Aldrich syndrome protein gene and their effects on transcriptional , translational , and clinical phenotypes .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Wiskott - Aldrich syndrome ( WAS ) is an X - linked recessive immunodeficiency characterized by thrombocytopenia , eczema , and recurrent infections , and caused by mutations in the WAS protein ( WASP ) gene .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'WASP contains several functional domains through which it interacts with proteins involved in intracellular signaling and regulation of the actin cytoskeleton .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In this report , 17 WASP gene mutations were identified , 12 of which are novel .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'DNA of affected males and obligate carriers was PCR amplified and analyzed by SSCA , heteroduplex analysis , and direct sequencing .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The effects of the mutations at the mRNA and protein level were ascertained by RT - PCR and Western blot analyses .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'All missense mutations were located in exons 1 - 4 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Most of the nonsense , frameshift and splice site mutations were found in exons 6 - 11 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutations that alter splice sites led to the synthesis of several types of mRNAs , a fraction of which represented the normally spliced product .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The presence of normally spliced transcripts was correlated with a milder phenotype .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'When one such case was studied by Western blotting , reduced amounts of normal - size WASP were present .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In other cases as well , a correlation was found between the amount of normal or mutant WASP present and the phenotypes of the affected individuals .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'No protein was detected in two individuals with severe WAS .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O']},\n",
       " {'sentence': 'Reduced levels of a normal - size WASP with a missense mutation were seen in two individuals with XLT .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'It is concluded that mutation analysis at the DNA level is not sufficient for predicting clinical course .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Studies at the transcript and protein level are needed for a better assessment . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Duchenne muscular dystrophy ( DMD ) is caused by mutations in the dystrophin gene , leading to the absence of the dystrophin protein in striated muscle .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A significant number of these mutations are premature stop codons .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'On the basis of the observation that aminoglycoside treatment can suppress stop codons in cultured cells , we tested the effect of gentamicin on cultured muscle cells from the mdx mouse - an animal model for DMD that possesses a premature stop codon in the dystrophin gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Exposure of mdx myotubes to gentamicin led to the expression and localization of dystrophin to the cell membrane .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We then evaluated the effects of differing dosages of gentamicin on expression and functional protection of the muscles of mdx mice .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We identified a treatment regimen that resulted in the presence of dystrophin in the cell membrane in all striated muscles examined and that provided functional protection against muscular injury .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'To our knowledge , our results are the first to demonstrate that aminoglycosides can suppress stop codons not only in vitro but also in vivo .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Furthermore , these results raise the possibility of a novel treatment regimen for muscular dystrophy and other diseases caused by premature stop codon mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This treatment could prove effective in up to 15 % of patients with DMD . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Loss of the ataxia - telangiectasia gene product causes oxidative damage in target organs .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Ataxia - telangiectasia ( A - T ) is characterized by a markedly increased sensitivity to ionizing radiation , increased incidence of cancer , and neurodegeneration , especially of the cerebellar Purkinje cells .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Ionizing radiation oxidizes macromolecules and causes tissue damage through the generation of reactive oxygen species ( ROS ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We therefore hypothesized that A - T is due to oxidative damage resulting from loss of function of the A - T gene product .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To assess this hypothesis , we employed an animal model of A - T , the mouse with a disrupted Atm gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We show that organs which develop pathologic changes in the Atm - deficient mice are targets of oxidative damage , and that cerebellar Purkinje cells are particularly affected .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These observations provide a mechanistic basis for the A - T phenotype and lay a rational foundation for therapeutic intervention . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Recessively inherited multiple epiphyseal dysplasia with normal stature , club foot , and double layered patella caused by a DTDST mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have observed over 25 different mutations in the diastrophic dysplasia sulphate transporter gene ( DTDST ) in association with the recessive disorders achondrogenesis 1B , atelosteogenesis 2 , and diastrophic dysplasia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The c862t ( R279W ) transition is the most common mutation in non - Finnish patients , but in these disorders it is usually combined with other DTDST mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We had not seen a case of homozygosity for c862t ( R279W ) until we analysed DNA from a 36 year old male with tall - normal stature ( 180 cm ) who asked for genetic counselling for suspected multiple epiphyseal dysplasia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'He was treated for club foot and hip dysplasia at birth .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'B', 'I', 'O', 'B', 'I', 'O', 'O', 'O']},\n",
       " {'sentence': 'Skeletal changes consistent with multiple epiphyseal dysplasia , with the peculiar finding of a double layered patella , were recognised during childhood .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Cleft palate , swelling of the ear pinna , and hitch hiker thumb were absent .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'He was found to be homozygous , and both healthy parents heterozygous , for the R279W mutation in DTDST , and his fibroblasts showed a sulphate incorporation defect typical of DTDST disorders .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Counselling was given for a recessive disorder , thereby considerably reducing the probability of affected offspring .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Multiple epiphyseal dysplasia is more frequently caused by dominant mutations in the COMP ( EDM1 , McKusick 132400 ) and COL9A2 genes ( EDM2 , McKusick 600204 ) .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A few other patients and families with features similar to our proband have been described previously and considered to have autosomal recessive MED ( EDM4 , McKusick 226900 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This observation confirms the existence of this entity and assigns it to the phenotypic spectrum associated with mutations at the DTDST locus . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': \"Homozygosity for a novel DTDST mutation in a child with a ' broad bone - platyspondylic ' variant of diastrophic dysplasia .\",\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Atypical or variant forms of well - known chondrodysplasias may pose diagnostic problems .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We report on a girl with clinical features suggesting diastrophic dysplasia but with unusual radiographic features including severe platyspondyly , wide metaphyses , and fibular overgrowth , which are partially reminiscent of metatropic dysplasia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'The diagnosis was clarified by molecular analysis of the DTDST gene , which revealed homozygosity for a previously undescribed mutation leading to a Q454P substitution in the 10th transmembrane domain of the DTDST sulfate transporter .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Molecular analysis may be of particular value in such atypical cases . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': \"The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation : a new facet to Knudson ' s ' two - hit ' hypothesis .\",\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'APC is often cited as a prime example of a tumor suppressor gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Truncating germline and somatic mutations ( or , infrequently , allelic loss ) occur in tumors in FAP ( familial adenomatous polyposis ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Most sporadic colorectal cancers also have two APC mutations .',\n",
       "  'entities': ['O', 'B', 'I', 'I', 'O', 'O', 'O', 'B', 'O', 'O']},\n",
       " {'sentence': 'Clues from attenuated polyposis , missense germline variants with mild disease and the somatic mutation cluster region ( codons 1 , 250 - 1 , 450 ) indicate , however , that APC mutations might not result in simple loss of protein function .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have found that FAP patients with germline APC mutations within a small region ( codons 1 , 194 - 1 , 392 at most ) mainly show allelic loss in their colorectal adenomas , in contrast to other FAP patients , whose second hits tend to occur by truncating mutations in the mutation cluster region .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our results indicate that different APC mutations provide cells with different selective advantages , with mutations close to codon 1 , 300 providing the greatest advantage .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Allelic loss is selected strongly in cells with one mutation near codon 1 , 300 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A different germline - somatic APC mutation association exists in FAP desmoids .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'APC is not , therefore , a classical tumor suppressor .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']},\n",
       " {'sentence': 'Our findings also indicate a new mechanism for disease severity if a broader spectrum of mutations is selected in tumors , the somatic mutation rate is effectively higher and more tumors grow . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mxi1 mutations in human neurofibrosarcomas .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'B', 'O']},\n",
       " {'sentence': 'Mxi1 is thought to negatively regulate Myc function and may therefore be a potential tumor suppressor gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Little effort has yet been made to find alterations involving this gene in human solid tumors .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'We screened 31 human gastric cancers , 7 esophageal cancers , 85 bone and soft tissue tumors of various types , including 4 neurofibrosarcomas .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'We also examined 29 human tumor cell lines consisting of 12 esophageal cancers , 7 glioma / glioblastomas and 10 others for Mxi1 mutations in exons 1 , 2 , 4 ( HLH domain ) , 5 and 6 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Polymerase chain reaction - single - strand conformation polymorphism ( PCR - SSCP ) and subsequent sequencing revealed three distinct polymorphisms in the intron - exon boundary upstream from exon 6 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We discovered a missense mutation , GCA to GTA ( Ala 54 Val ) , in exon 2 in a neurofibrosarcoma patient ( case 1 ) , two missense mutations , AAA to CAA ( Lys 118 Gln ) and GAA to GGA ( Glu 154 Gly ) in exon 5 of another neurofibrosarcoma patient ( case 2 ) , and 3 amino acid substitutions , GTG to GCG ( Val 179 Ala ) , GTT to GCT ( Val 181 Ala ) and TTC to CTC ( Phe 186 Leu ) , in a third neurofibrosarcoma patient ( case 3 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In case 3 , loss of heterozygosity was also demonstrated by informative ( TTC ) 3 / ( TTC ) 2 polymorphism .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our data demonstrate that mutations occur in the Mxi1 gene in neurofibrosarcoma .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Missense mutations in the functional domain of Mxi1 in these cases may be involved in the pathogenesis of neurofibrosarcoma . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A population - based study of the clinical expression of the hemochromatosis gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'BACKGROUND AND METHODS Hereditary hemochromatosis is associated with homozygosity for the C282Y mutation in the hemochromatosis ( HFE ) gene on chromosome 6 , elevated serum transferrin saturation , and excess iron deposits throughout the body .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To assess the prevalence and clinical expression of the HFE gene , we conducted a population - based study in Busselton , Australia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In 1994 , we obtained blood samples for the determination of serum transferrin saturation and ferritin levels and the presence or absence of the C282Y mutation and the H63D mutation ( which may contribute to increased hepatic iron levels ) in 3011 unrelated white adults .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We evaluated all subjects who had persistently elevated transferrin - saturation values ( 45 percent or higher ) or were homozygous for the C282Y mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We recommended liver biopsy for subjects with serum ferritin levels of 300 ng per milliliter or higher .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The subjects were followed for up to four years .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'RESULTS Sixteen of the subjects ( 0 . 5 percent ) were homozygous for the C282Y mutation , and 424 ( 14 . 1 percent ) were heterozygous .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The serum transferrin saturation was 45 percent or higher in 15 of the 16 who were homozygous ; in 1 subject it was 43 percent .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Four of the homozygous subjects had previously been given a diagnosis of hemochromatosis , and 12 had not .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Seven of these 12 patients had elevated serum ferritin levels in 1994 ; 6 of the 7 had further increases in 1998 , and 1 had a decrease , although the value remained elevated .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The serum ferritin levels in the four other homozygous patients remained in the normal range .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Eleven of the 16 homozygous subjects underwent liver biopsy ; 3 had hepatic fibrosis , and 1 , who had a history of excessive alcohol consumption , had cirrhosis and mild microvesicular steatosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Eight of the 16 homozygous subjects had clinical findings that were consistent with the presence of hereditary hemochromatosis , such as hepatomegaly , skin pigmentation , and arthritis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'CONCLUSIONS In a population of white adults of northern European ancestry , 0 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '5 percent were homozygous for the C282Y mutation in the HFE gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'However , only half of those who were homozygous had clinical features of hemochromatosis , and one quarter had serum ferritin levels that remained normal over a four - year period .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Large heterozygous deletion masquerading as homozygous missense mutation : a pitfall in diagnostic mutation analysis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The clinical use of molecular analyses in recessive disorders relies on the exact characterization of both mutant alleles in the affected patient .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This can be problematic when only part of the gene is examined or when relevant DNA alterations are not recognized by standard methods .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We present a child in whom phenylketonuria was apparently caused by homozygosity for the mutation E390G in exon 11 of the phenylalanine hydroxylase ( PAH ) gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'However , the clinical severity of the disease was not quite as mild as expected , the mutation was not identified in the father despite confirmed paternity , and the paternal allele showed a highly unusual pattern of polymorphic markers in the PAH gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Presence of a large deletion involving exons 9 , 10 and 11 of the phenylalanine hydroxylase gene was confirmed by long - range PCR .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Diagnostic DNA analyses should include a comprehensive examination of the whole relevant gene in the patient and confirmation of carrier status in both parents . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Early onset of X - linked Emery - Dreifuss muscular dystrophy in a boy with emerin gene deletion .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A boy developed contractures of the Achilles tendons at 3 years and of the postcervical muscles at 7 years , although neither contractures of the elbows nor cardiac abnormality were recognized by the age of 9 years .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Muscle computed tomography scanning revealed changes characteristic of muscle involvement .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Emerin was not detected in the biopsied muscle , and RT - PCR and PCR - based genomic DNA analyses of the emerin gene demonstrated no amplification product in the patient .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These results confirmed the diagnosis of X - linked Emery - Dreifuss muscular dystrophy ( EDMD ) , and reinforce the necessity of molecular genetic diagnosis of the membrane protein emerin in younger patients with possible EDMD before appearance of the typical symptoms , to avoid sudden cardiac death . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Duchenne / Becker muscular dystrophy : correlation of phenotype by electroretinography with sites of dystrophin mutations .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The dark - adapted electroretinogram ( ERG ) of patients with Duchenne and Becker muscular dystrophy ( DMD / BMD ) shows a marked reduction in b - wave amplitude .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Genotype - phenotype studies of mouse models for DMD show position - specific effects of the mutations upon the phenotype mice with 5 defects of dystrophin have normal ERGs , those with defects in the central region have a normal b - wave amplitude associated with prolonged implicit times for both the b - wave and oscillatory potentials , and mice with 3 defects have a phenotype similar to that seen in DMD / BMD patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The mouse studies suggest a key role for the carboxyl terminal dystrophin isoform , Dp260 , in retinal electrophysiology .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have undertaken a systematic evaluation of DMD / BMD patients through clinical examination and review of the literature in order to determine whether the position - specific effects of mutations noted in the mouse are present in man .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have found that , in man , a wider variation of DMD defects correlate with reductions in the b - wave amplitude .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Individuals with normal ERGs have mutations predominantly located 5 of the transcript initiation site of Dp260 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our results suggest that the most important determinant in the ERG b - wave phenotype is the mutation position , rather than muscle disease severity .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Forty - six per cent of patients with mutations 5 of the Dp260 transcript start site have abnormal ERGs , as opposed to 94 % with more distal mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The human genotype - phenotype correlations are consistent with a role for Dp260 in normal retinal electrophysiology and may also reflect the expression of other C - terminal dystrophin isoforms and their contributions to retinal signal transmission . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Cis and trans effects of the myotonic dystrophy ( DM ) mutation in a cell culture model .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The mutation causing myotonic dystrophy ( DM ) has been identified as a CTG expansion in the 3 - untranslated region ( 3 - UTR ) of the DM protein kinase gene ( DMPK ) , but the mechanism ( s ) of pathogenesis remain unknown .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Studies using DM patient materials have often produced confusing results .',\n",
       "  'entities': ['O', 'O', 'B', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Therefore , to study the effects of the DM mutation in a controlled environment , we have established a cell culture model system using C2C12 mouse myoblasts .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'By expressing chimeric reporter constructs containing a reporter gene fused to a human DMPK 3 - UTR , we identified both cis and trans effects that are mediated by the DM mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our data show that a mutant DMPK 3 - UTR , with as few as 57 CTGs , had a negative cis effect on protein expression and resulted in the aggregation of reporter transcripts into discrete nuclear foci .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We determined by deletion analysis that an expanded ( CTG ) ( n ) tract alone was sufficient to mediate these cis effects .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Furthermore , in contrast to the normal DMPK 3 - UTR mRNA , a mutant DMPK 3 - UTR mRNA with ( CUG ) ( 200 ) selectively inhibited myogenic differentiation of C2C12 myoblasts .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Genetic analysis and the Cre - loxP system were used to clearly demonstrate that the myoblast fusion defect could be rescued by eliminating the expression of the mutant DMPK 3 - UTR transcript .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Characterization of spontaneous deletion events mapped the inhibitory effect to the ( CTG ) ( n ) expansion and / or the 3 end of the DMPK 3 - UTR .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'These results provide evidence that the DM mutation acts in cis to reduce protein production ( consistent with DMPK haploinsufficiency ) and in trans as a riboregulator to inhibit myogenesis . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': \"Coats ' disease of the retina ( unilateral retinal telangiectasis ) caused by somatic mutation in the NDP gene : a role for norrin in retinal angiogenesis .\",\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Coats disease is characterized by abnormal retinal vascular development ( so - called retinal telangiectasis ) which results in massive intraretinal and subretinal lipid accumulation ( exudative retinal detachment ) .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The classical form of Coats disease is almost invariably isolated , unilateral and seen in males .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A female with a unilateral variant of Coats disease gave birth to a son affected by Norrie disease .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Both carried a missense mutation within the NDP gene on chromosome Xp11 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '2 2 .', 'entities': ['O', 'O', 'O']},\n",
       " {'sentence': 'Subsequently analysis of the retinas of nine enucleated eyes from males with Coats disease demonstrated in one a somatic mutation in the NDP gene which was not present within non - retinal tissue .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We suggest that Coats telangiectasis is secondary to somatic mutation in the NDP gene which results in a deficiency of norrin ( the protein product of the NDP gene ) within the developing retina .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'This supports recent observations that the protein is critical for normal retinal vasculogenesis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li - Fraumeni syndrome family .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Li - Fraumeni syndrome is an autosomal dominant disorder that is characterized by various types of cancer in childhood and adult cases .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Although hereditary TP53 mutation is very rare in different human cancers , it has been frequently reported in Li - Fraumeni syndrome .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'On the other hand , hereditary mutations of TP57KIP2 , P15INK4B , and P16INK4A , which affect the cell cycle similar to TP53 , were observed in some types of cancer .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'In a Turkish family with the diagnosis of Li - Fraumeni syndrome , we analyzed the mutation pattern of TP53 , P57KIP2 , P15INK4B , and P16INK4A in the peripheral blood , and loss of heterozygosity ( homo / hemizygous deletion ) pattern of TP53 and P15INK4B / P16INK4A in two tumor tissues .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The propositus had a seminoma , his daughter a medulloblastoma , and one of his healthy cousins , a TP53 codon 292 missense point mutation ( AAA - - > ATA ; Lys - - > Ile ) in the peripheral blood cells .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Tumor tissue obtained from the propositus with the seminoma revealed loss of heterozygosity in the TP53 gene .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In the analyses of tumor tissues from the propositus and his daughter , a P16INK4A codon 94 missense point mutation ( GCG - - > GAG ; Ala - - > Glu ) was observed with the hereditary TP53 mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'P16INK4A codon 94 mutation observed in our family is a novel mutation in Li - Fraumeni syndrome .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'No other gene alteration in TP53 , P57KIP2 , P15INK4B , and P16INK4A was observed .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Existence of the P16INK4A mutation and the hereditary TP53 mutation with or without loss of heterozygosity in the TP53 gene ( seminoma / medulloblastoma ) may be evidence for a common mechanism involved in tumorogenesis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'The gene alterations in TP53 and P16INK4A genes may be used as tumor markers in our family . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A novel mutation in the sodium / iodide symporter gene in the largest family with iodide transport defect .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'We previously reported nine children with an autosomally recessive form of congenital hypothyroidism due to an iodide transport defect in a large Hutterite family with extensive consanguinity living in central Canada .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Since the original report , we have diagnosed congenital hypothyroidism by newborn TSH screening in 9 additional children from the family .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We performed direct sequencing of the PCR products of each NIS ( sodium / iodide symporter ) gene exon with flanking introns amplified from genomic DNA extracted from peripheral blood cells of the patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We identified a novel NIS gene mutation , G395R ( Gly395 - - > Arg ; GGA - - > AGA ) , in 10 patients examined in the present study .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'All of the parents tested were heterozygous for the mutation , suggesting that the patients were homozygous .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The mutation was located in the 10th transmembrane helix .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Expression experiments by transfection of the mutant NIS complimentary DNA into COS - 7 cells showed no perchlorate - sensitive iodide uptake , confirming that the mutation is the direct cause of the iodide transport defect in these patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A patient who showed an intermediate saliva / serum technetium ratio ( 14 . 0 ; normal , > or = 20 ) and was considered to have a partial or less severe defect in the previous report ( IX - 24 ) did not have a NIS gene mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'It is now possible to use gene diagnostics of this unique NIS mutation to identify patients with congenital hypothyroidism due to an iodide transport defect in this family and to determine the carrier state of potential parents for genetic counseling and arranging rapid and early diagnosis of their infants .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Molecular analysis in familial neurohypophyseal diabetes insipidus : early diagnosis of an asymptomatic carrier .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Familial neurohypophyseal diabetes insipidus ( FNDI ) is an inherited deficiency of the hormone arginine vasopressin ( AVP ) and is transmitted as an autosomal dominant trait .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In the present study we have analyzed the AVP - neurophysin II ( AVP - NPII ) gene in a Spanish kindred .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Studies were performed on seven members ( four clinically affected ) of the family .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Patients were diagnosed at the Hospital Universitario Gregorio Maranon ( Madrid , Spain ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The entire coding region of the AVP - NPII gene of all family members was amplified by PCR and sequenced .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'All affected individuals presented a missense mutation ( G1757 - - > A ) that replaces glycine at position 23 with arginine within the NPII domain .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The substitution was confirmed by restriction endonuclease analysis and was present in heterozygosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Additionally , one of the asymptomatic relatives ( a girl 8 months old at the time of study ) was identified as carrier of the same mutation and developed the disease 3 months later .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The alteration found in the second exon of the gene in this family seems to be responsible for the disease , as all individuals harboring the mutation had been previously diagnosed or have eventually developed FNDI .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Identification of the molecular defect underlying FNDI in affected families is a powerful tool for early asymptomatic diagnosis in infants . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'Friedreich ataxia ( FRDA ) , the most common of the inherited ataxias , is an autosomal recessive degenerative disorder , characterized clinically by onset before the age of 25 of progressive gait and limb ataxia , absence of deep tendon reflexes , extensor plantar responses , and loss of position and vibration sense in the lower limbs .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'FRDA is caused by a GAA triplet expansion in the first intron of the FRDA gene on chromosome 9q13 in 97 % of patients .',\n",
       "  'entities': ['B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The FRDA gene encodes a widely expressed 210 - aa protein , frataxin , which is located in mitochondria and is severely reduced in FRDA patients .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Frataxin function is still unknown but the knockout of the yeast frataxin homologue gene ( YFH1 ) showed a severe defect of mitochondrial respiration and loss of mtDNA associated with elevated intramitochondrial iron .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Here we report in vivo evidence of impaired mitochondrial respiration in skeletal muscle of FRDA patients .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Using phosphorus magnetic resonance spectroscopy we demonstrated a maximum rate of muscle mitochondrial ATP production ( V ( max ) ) below the normal range in all 12 FRDA patients and a strong negative correlation between mitochondrial V ( max ) and the number of GAA repeats in the smaller allele .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Our results show that FRDA is a nuclear - encoded mitochondrial disorder affecting oxidative phosphorylation and give a rationale for treatments aimed to improve mitochondrial function in this condition . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Identification of a novel R21X mutation in the liver - type arginase gene ( ARG1 ) in four Portuguese patients with argininemia .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'Argininemia is a rare autossomal recessive disorder caused by deficiency in the cytosolic liver - type arginase enzyme ( L - arginine urea - hydrolase ; E . C . 3 . 5 . 3 . 1 ) .',\n",
       "  'entities': ['B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In order to investigate the molecular basis for argininemia in four unrelated Portuguese patients ( two from northern Portugal and two from Madeira Island ) we performed a DNA sequence analysis of all the exons and exon / intron boundaries of the liver - type arginase gene ( ARG1 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'All patients were found to be homozygous for a newly identified C - > T transition in codon 21 ( exon 2 ) substituting arginine for a premature stop codon ( R21X CGA to TGA ) and generating a NlaIII restriction site .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Restriction digestion following PCR amplification of ARG1 exon 2 confirmed the presence of the mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutation of the sterol 27 - hydroxylase gene ( CYP27 ) results in truncation of mRNA expressed in leucocytes in a Japanese family with cerebrotendinous xanthomatosis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'OBJECTIVES A Japanese family with cerebrotendinous xanthomatosis ( CTX ) was investigated for a sequence alteration in the sterol 27 - hydroxylase gene ( CYP27 ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The expression of CYP27 has been mostly explored using cultured fibroblasts , prompting the examination of the transcripts from blood leucocytes as a simple and rapid technique .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'METHODS An alteration in CYP27 of the proband was searched for by polymerase chain reaction - single strand conformation polymorphism ( PCR - SSCP ) analysis and subsequent sequencing .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Samples of RNA were subjected to reverse transcription PCR ( RT - PCR ) and the product of the proband was amplified with nested primers and sequenced .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'RESULTS A homozygous G to A transition at the 5 end of intron 7 was detected in the patient .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In RT - PCR analysis , only a truncated transcript was detected in the patient , whereas both normal and truncated transcripts were detected in the siblings .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The sequencing of the patients cDNA fragment disclosed a direct conjuction of exon 6 and exon 8 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'CONCLUSION The mutation at splice donor site and the truncation of mRNA were identical with those of a recently reported Italian patient , although different in symptomatology .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The application of blood leucocytes can be a simple technique on analysing a constructive abnormality of CYP27 mRNA . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile - onset diabetes mellitus and progressive optic atrophy .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'mtDNA deletions have been described , and a gene ( WFS1 ) recently has been identified , on chromosome 4p16 , encoding a predicted 890 amino acid transmembrane protein .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Direct DNA sequencing was done to screen the entire coding region of the WFS1 gene in 30 patients from 19 British kindreds with Wolfram syndrome .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " {'sentence': 'DNA was also screened for structural rearrangements ( deletions and duplications ) and point mutations in mtDNA .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'No pathogenic mtDNA mutations were found in our cohort .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'We identified 24 mutations in the WFS1 gene 8 nonsense mutations , 8 missense mutations , 3 in - frame deletions , 1 in - frame insertion , and 4 frameshift mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Of these , 23 were novel mutations , and most occurred in exon 8 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The majority of patients were compound heterozygotes for two mutations , and there was no common founder mutation .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The data were also analyzed for genotype - phenotype relationships .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Although some interesting cases were noted , consideration of the small sample size and frequency of each mutation indicated no clear - cut correlations between any of the observed mutations and disease severity .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'There were no obvious mutation hot spots or clusters .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'Hence , molecular screening for Wolfram syndrome in affected families and for Wolfram syndrome - carrier status in subjects with psychiatric disorders or diabetes mellitus will require complete analysis of exon 8 and upstream exons . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Late - onset familial Mediterranean fever ( FMF ) : a subset with distinct clinical , demographic , and molecular genetic characteristics .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'To determine the prevalence and characterize demographic , clinical , and genetic features of familial Mediterranean fever ( FMF ) of late onset , all patients experiencing their first FMF attack at age 40 years or more were identified using the computerized registry of our FMF clinic , and then thoroughly interviewed and examined .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The control group consisted of 40 consecutive FMF patients , who arrived at the FMF clinic for their regular follow - up visit and were 40 years of age or older at the time of the examination .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The severity of the disease in patients and controls was determined using a modified score , developed previously .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Mutational analysis in the FMF gene was performed using a commercial kit .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Only 20 of 4000 ( 0 . 5 % ) patients had late - onset FMF .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O']},\n",
       " {'sentence': 'These patients were mostly men , of non - North African origin , P < 0 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '05 compared to controls .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'All had abdominal attacks and in most these were the only manifestation of their disease , P < 0 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '001 001 .', 'entities': ['O', 'O', 'O']},\n",
       " {'sentence': 'None had chronic or prolonged manifestations of FMF , for example , amyloidosis , chronic arthritis , or protracted myalgia , P < 0 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '001 .', 'entities': ['O', 'O']},\n",
       " {'sentence': 'The response to treatment was good despite using low colchicine dose , P < 0 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '05 .', 'entities': ['O', 'O']},\n",
       " {'sentence': 'The overall severity score indicated a mild disease , P < 0 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': '001 .', 'entities': ['O', 'O']},\n",
       " {'sentence': 'Mutational analysis revealed absence of M694V homozygosity , P < 0 .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': '01 , compared to our regular FMF population .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'B', 'O', 'O']},\n",
       " {'sentence': 'We conclude that the onset of FMF in a late age defines a milder form of disease with typical clinical , demographic , and molecular genetic characteristics',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'A highly accurate , low cost test for BRCA1 mutations .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The hereditary breast and ovarian cancer syndrome is associated with a high frequency of BRCA1 mutations .',\n",
       "  'entities': ['O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'However , the widespread use of BRCA1 testing has been limited to date by three principal concerns the fear of loss of health and life insurance , the uncertain clinical value of a positive test result , and the current lack of an inexpensive and sensitive screening test for BRCA1 mutations .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We have developed an inexpensive system for gene mutational scanning , based on a combination of extensive multiplex PCR amplification and two dimensional electrophoresis .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'The efficiency of this system , as a screening test for BRCA1 mutations , was evaluated in a panel of 60 samples from high risk women , 14 of which contained a previously identified mutation in BRCA1 .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'All 14 mutations were identified , as well as an additional five that had previously escaped detection .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'In addition to the 19 mutations , a total of 15 different polymorphic variants were scored , most of which were recurring .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'All were confirmed by nucleotide sequencing .',\n",
       "  'entities': ['O', 'O', 'O', 'O', 'O', 'O', 'O']},\n",
       " {'sentence': 'The cost of screening per sample was calculated to be approximately US $ 70 for the manual technique used in this study , and may be reduced to approximately US $ 10 with the introduction of commercially available PCR robotics and fluorescent imaging .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Implementation of this method of mutation screening in the research and clinical setting should permit rapid accrual of quantitative data on genotype - phenotype associations for the evaluation of diagnostic testing . .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'Maternal uniparental disomy for chromosome 14 in a boy with a normal karyotype .',\n",
       "  'entities': ['B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'We report on a boy with a maternal uniparental disomy for chromosome 14 ( UPD ( 14 ) ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'At 7 years of age he was referred to us by the paediatrician because of symptoms of Prader - Willi syndrome ( PWS ) .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'I',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O']},\n",
       " {'sentence': 'He showed short stature , obesity , mild developmental delay , cryptorchidism , and some mild dysmorphic features .',\n",
       "  'entities': ['O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O',\n",
       "   'B',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'O',\n",
       "   'B',\n",
       "   'I',\n",
       "   'O']},\n",
       " ...]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(6347, 3)"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Check how many datapoints and unique labels we have acquired from the dataset\n",
    "\n",
    "len(data), len(unq_labels)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Feature Engineering"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Now we will make reference dictionaries for the text elements\n",
    "\n",
    "def get_mappings(data, word_ent):\n",
    "\n",
    "    if word_ent == \"word\":\n",
    "        vocab = list(set([i for x in data for i in x['sentence'].split()]))\n",
    "    elif word_ent == \"ent\":\n",
    "        vocab = list(set([i for x in data for i in x['entities']]))\n",
    "    \n",
    "    idx2tok = {idx:tok for  idx, tok in enumerate(vocab)}\n",
    "    tok2idx = {tok:idx for  idx, tok in enumerate(vocab)}\n",
    "    \n",
    "    return tok2idx, idx2tok\n",
    "\n",
    "\n",
    "word2idx, idx2word = get_mappings(data, \"word\")\n",
    "tag2idx, idx2tag = get_mappings(data, \"ent\")\n",
    "\n",
    "n_words = len(word2idx)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "# We will add a PAD token to consider padding during training\n",
    "\n",
    "word2idx[\"PAD\"] = n_words\n",
    "idx2word[n_words] = \"PAD\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "There are 10057 unique words/elements in the corpus being considered\n"
     ]
    }
   ],
   "source": [
    "n_words = len(word2idx)\n",
    "\n",
    "print(\"There are {} unique words/elements in the corpus being considered\".format(n_words))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "For convenience let us create a Pandas df summarising all the reelvant data to this point"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "columns = [\"Sentence\", \"Labels\", \"Word Tokens\", \"Label Tokens\"]\n",
    "\n",
    "data_df = []\n",
    "for i in range(len(data)):\n",
    "    #We want data in the form : [Sentence, Labels, Words Tokens, Label Tokens]\n",
    "    sentence = data[i]['sentence']\n",
    "    labels = data[i]['entities']\n",
    "    words = sentence.split()\n",
    "    word_tkns = [word2idx.get(i) for i in words]\n",
    "    label_tkns = [tag2idx.get(i) for i in labels]\n",
    "    \n",
    "    data_df.append([sentence, labels, word_tkns, label_tkns])\n",
    "    \n",
    "data_df = pd.DataFrame(data_df, columns = columns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sentence</th>\n",
       "      <th>Labels</th>\n",
       "      <th>Word Tokens</th>\n",
       "      <th>Label Tokens</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Identification of APC2 , a homologue of the ad...</td>\n",
       "      <td>[O, O, O, O, O, O, O, O, B, I, I, I, O, O]</td>\n",
       "      <td>[2185, 9830, 7251, 5779, 1606, 2140, 9830, 875...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 0, 2, 2, 2, 1, 1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>The adenomatous polyposis coli ( APC ) tumour ...</td>\n",
       "      <td>[O, B, I, I, I, I, I, I, O, O, O, O, O, O, O, ...</td>\n",
       "      <td>[7515, 7130, 16, 3834, 524, 9376, 621, 1337, 6...</td>\n",
       "      <td>[1, 0, 2, 2, 2, 2, 2, 2, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Complex formation induces the rapid degradatio...</td>\n",
       "      <td>[O, O, O, O, O, O, O, O, O]</td>\n",
       "      <td>[2905, 6673, 8949, 8758, 6680, 3297, 9830, 846...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>In colon carcinoma cells , loss of APC leads t...</td>\n",
       "      <td>[O, B, I, O, O, O, O, O, O, O, O, O, O, O, O, ...</td>\n",
       "      <td>[2474, 3352, 7587, 8128, 5779, 4597, 9830, 937...</td>\n",
       "      <td>[1, 0, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Here , we report the identification and genomi...</td>\n",
       "      <td>[O, O, O, O, O, O, O, O, O, O, O, O, O]</td>\n",
       "      <td>[4869, 5779, 2266, 2086, 8758, 315, 72, 7803, ...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Sentence  \\\n",
       "0  Identification of APC2 , a homologue of the ad...   \n",
       "1  The adenomatous polyposis coli ( APC ) tumour ...   \n",
       "2  Complex formation induces the rapid degradatio...   \n",
       "3  In colon carcinoma cells , loss of APC leads t...   \n",
       "4  Here , we report the identification and genomi...   \n",
       "\n",
       "                                              Labels  \\\n",
       "0         [O, O, O, O, O, O, O, O, B, I, I, I, O, O]   \n",
       "1  [O, B, I, I, I, I, I, I, O, O, O, O, O, O, O, ...   \n",
       "2                        [O, O, O, O, O, O, O, O, O]   \n",
       "3  [O, B, I, O, O, O, O, O, O, O, O, O, O, O, O, ...   \n",
       "4            [O, O, O, O, O, O, O, O, O, O, O, O, O]   \n",
       "\n",
       "                                         Word Tokens  \\\n",
       "0  [2185, 9830, 7251, 5779, 1606, 2140, 9830, 875...   \n",
       "1  [7515, 7130, 16, 3834, 524, 9376, 621, 1337, 6...   \n",
       "2  [2905, 6673, 8949, 8758, 6680, 3297, 9830, 846...   \n",
       "3  [2474, 3352, 7587, 8128, 5779, 4597, 9830, 937...   \n",
       "4  [4869, 5779, 2266, 2086, 8758, 315, 72, 7803, ...   \n",
       "\n",
       "                                        Label Tokens  \n",
       "0         [1, 1, 1, 1, 1, 1, 1, 1, 0, 2, 2, 2, 1, 1]  \n",
       "1  [1, 0, 2, 2, 2, 2, 2, 2, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "2                        [1, 1, 1, 1, 1, 1, 1, 1, 1]  \n",
       "3  [1, 0, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "4            [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]  "
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "del train_dev_data, data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Let us look at the sentence lengths and find an appropriate padding length"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "count    6347.000000\n",
       "mean       25.156767\n",
       "std        12.523920\n",
       "min         2.000000\n",
       "25%        16.000000\n",
       "50%        23.000000\n",
       "75%        32.000000\n",
       "max       123.000000\n",
       "Name: Word Tokens, dtype: float64"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lengths = data_df['Word Tokens'].map(len)\n",
    "\n",
    "lengths.hist()\n",
    "plt.show()\n",
    "\n",
    "lengths.describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'PAD'"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "idx2word[n_words-1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "MAX_PAD = 50\n",
    "\n",
    "padded_sentences = pad_sequences(data_df[\"Word Tokens\"], maxlen=MAX_PAD, dtype='int32', padding='post', truncating='post', value= n_words - 1)\n",
    "padded_labels = pad_sequences(data_df[\"Label Tokens\"], maxlen = MAX_PAD, dtype='int32', padding='post', truncating='post', value= tag2idx[\"O\"])\n",
    "padded_labels = np.array([to_categorical(i, num_classes = len(tag2idx)) for i in padded_labels])\n",
    "\n",
    "no_samples = np.shape(padded_sentences)[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [1., 0., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [1., 0., 0.],\n",
       "       [0., 0., 1.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.],\n",
       "       [0., 1., 0.]], dtype=float32)"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "padded_labels[10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['A',\n",
       " 'common',\n",
       " 'MSH2',\n",
       " 'mutation',\n",
       " 'in',\n",
       " 'English',\n",
       " 'and',\n",
       " 'North',\n",
       " 'American',\n",
       " 'HNPCC',\n",
       " 'families',\n",
       " ':',\n",
       " 'origin',\n",
       " ',',\n",
       " 'phenotypic',\n",
       " 'expression',\n",
       " ',',\n",
       " 'and',\n",
       " 'sex',\n",
       " 'specific',\n",
       " 'differences',\n",
       " 'in',\n",
       " 'colorectal',\n",
       " 'cancer',\n",
       " '.',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD',\n",
       " 'PAD']"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "[idx2word[i] for i in padded_sentences[10]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "idx = list(range(no_samples))\n",
    "\n",
    "train_idx, val_test_idx = train_test_split(idx, test_size = 0.6, shuffle = True, random_state = 2021)\n",
    "val_idx, test_idx = train_test_split(val_test_idx, test_size = 0.5)\n",
    "\n",
    "train_sent, train_labels = padded_sentences[train_idx], padded_labels[train_idx]\n",
    "val_sent, val_labels = padded_sentences[val_idx], padded_labels[val_idx]\n",
    "test_sent, test_labels = padded_sentences[test_idx], padded_labels[test_idx]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Build Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_model(vocab_size, lr = 0.001):\n",
    "    EMB_DIM = 64\n",
    "\n",
    "    inputs = Input(shape = (50,))\n",
    "\n",
    "    emb = Embedding(input_dim=vocab_size + 1, output_dim=EMB_DIM, trainable = True, name = \"embed\")\n",
    "    lstm = Bidirectional(LSTM(units=EMB_DIM, return_sequences=True, dropout=0.2), merge_mode = 'concat', name = \"bilstm\")\n",
    "    tdd = TimeDistributed(Dense(3, activation=\"softmax\"), name = \"tdd\")\n",
    "    \n",
    "    x = emb(inputs)\n",
    "    x = lstm(x)\n",
    "    output = tdd(x)\n",
    "\n",
    "    model = Model(inputs, output)\n",
    "\n",
    "    model.compile(loss='categorical_crossentropy', optimizer=Adam(lr=lr, beta_1=0.9, beta_2=0.999), metrics=['accuracy'])\n",
    "    model.summary()\n",
    "    \n",
    "    return model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model: \"model_4\"\n",
      "_________________________________________________________________\n",
      "Layer (type)                 Output Shape              Param #   \n",
      "=================================================================\n",
      "input_5 (InputLayer)         [(None, 50)]              0         \n",
      "_________________________________________________________________\n",
      "embed (Embedding)            (None, 50, 64)            643712    \n",
      "_________________________________________________________________\n",
      "bilstm (Bidirectional)       (None, 50, 128)           66048     \n",
      "_________________________________________________________________\n",
      "tdd (TimeDistributed)        (None, 50, 3)             387       \n",
      "=================================================================\n",
      "Total params: 710,147\n",
      "Trainable params: 710,147\n",
      "Non-trainable params: 0\n",
      "_________________________________________________________________\n"
     ]
    }
   ],
   "source": [
    "model = get_model(n_words, lr = 0.0005)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Train on 2538 samples, validate on 1904 samples\n",
      "Epoch 1/100\n",
      "2538/2538 [==============================] - 6s 2ms/sample - loss: 0.6407 - accuracy: 0.9249 - val_loss: 0.2176 - val_accuracy: 0.9593\n",
      "Epoch 2/100\n",
      "2538/2538 [==============================] - 2s 973us/sample - loss: 0.1898 - accuracy: 0.9584 - val_loss: 0.1738 - val_accuracy: 0.9593\n",
      "Epoch 3/100\n",
      "2538/2538 [==============================] - 2s 972us/sample - loss: 0.1688 - accuracy: 0.9584 - val_loss: 0.1619 - val_accuracy: 0.9593\n",
      "Epoch 4/100\n",
      "2538/2538 [==============================] - 3s 997us/sample - loss: 0.1559 - accuracy: 0.9584 - val_loss: 0.1510 - val_accuracy: 0.9593\n",
      "Epoch 5/100\n",
      "2538/2538 [==============================] - 2s 977us/sample - loss: 0.1419 - accuracy: 0.9585 - val_loss: 0.1378 - val_accuracy: 0.9593\n",
      "Epoch 6/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.1251 - accuracy: 0.9586 - val_loss: 0.1202 - val_accuracy: 0.9598\n",
      "Epoch 7/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.1045 - accuracy: 0.9617 - val_loss: 0.1011 - val_accuracy: 0.9643\n",
      "Epoch 8/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0849 - accuracy: 0.9682 - val_loss: 0.0860 - val_accuracy: 0.9698\n",
      "Epoch 9/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0701 - accuracy: 0.9726 - val_loss: 0.0771 - val_accuracy: 0.9729\n",
      "Epoch 10/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0599 - accuracy: 0.9765 - val_loss: 0.0715 - val_accuracy: 0.9746\n",
      "Epoch 11/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0522 - accuracy: 0.9798 - val_loss: 0.0714 - val_accuracy: 0.9758\n",
      "Epoch 12/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0474 - accuracy: 0.9822 - val_loss: 0.0660 - val_accuracy: 0.9775\n",
      "Epoch 13/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0419 - accuracy: 0.9843 - val_loss: 0.0675 - val_accuracy: 0.9779\n",
      "Epoch 14/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0379 - accuracy: 0.9862 - val_loss: 0.0635 - val_accuracy: 0.9795\n",
      "Epoch 15/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0347 - accuracy: 0.9872 - val_loss: 0.0696 - val_accuracy: 0.9787\n",
      "Epoch 16/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0308 - accuracy: 0.9886 - val_loss: 0.0659 - val_accuracy: 0.9801\n",
      "Epoch 17/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0274 - accuracy: 0.9900 - val_loss: 0.0641 - val_accuracy: 0.9808\n",
      "Epoch 18/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0247 - accuracy: 0.9911 - val_loss: 0.0657 - val_accuracy: 0.9811\n",
      "Epoch 19/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0224 - accuracy: 0.9920 - val_loss: 0.0647 - val_accuracy: 0.9819\n",
      "Epoch 20/100\n",
      "2538/2538 [==============================] - 3s 985us/sample - loss: 0.0201 - accuracy: 0.9931 - val_loss: 0.0689 - val_accuracy: 0.9821\n",
      "Epoch 21/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0179 - accuracy: 0.9939 - val_loss: 0.0697 - val_accuracy: 0.9822\n",
      "Epoch 22/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0163 - accuracy: 0.9948 - val_loss: 0.0660 - val_accuracy: 0.9830\n",
      "Epoch 23/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0149 - accuracy: 0.9954 - val_loss: 0.0757 - val_accuracy: 0.9824\n",
      "Epoch 24/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0136 - accuracy: 0.9961 - val_loss: 0.0708 - val_accuracy: 0.9832\n",
      "Epoch 25/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0123 - accuracy: 0.9967 - val_loss: 0.0745 - val_accuracy: 0.9832\n",
      "Epoch 26/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0116 - accuracy: 0.9969 - val_loss: 0.0770 - val_accuracy: 0.9833\n",
      "Epoch 27/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0104 - accuracy: 0.9973 - val_loss: 0.0769 - val_accuracy: 0.9833\n",
      "Epoch 28/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0097 - accuracy: 0.9975 - val_loss: 0.0795 - val_accuracy: 0.9829\n",
      "Epoch 29/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0087 - accuracy: 0.9979 - val_loss: 0.0753 - val_accuracy: 0.9834\n",
      "Epoch 30/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0083 - accuracy: 0.9980 - val_loss: 0.0755 - val_accuracy: 0.9834\n",
      "Epoch 31/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0074 - accuracy: 0.9982 - val_loss: 0.0790 - val_accuracy: 0.9837\n",
      "Epoch 32/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0068 - accuracy: 0.9983 - val_loss: 0.0820 - val_accuracy: 0.9836\n",
      "Epoch 33/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0062 - accuracy: 0.9986 - val_loss: 0.0849 - val_accuracy: 0.9833\n",
      "Epoch 34/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0061 - accuracy: 0.9987 - val_loss: 0.0789 - val_accuracy: 0.9834\n",
      "Epoch 35/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0054 - accuracy: 0.9989 - val_loss: 0.0887 - val_accuracy: 0.9831\n",
      "Epoch 36/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0054 - accuracy: 0.9988 - val_loss: 0.0846 - val_accuracy: 0.9837\n",
      "Epoch 37/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0048 - accuracy: 0.9990 - val_loss: 0.0814 - val_accuracy: 0.9839\n",
      "Epoch 38/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0044 - accuracy: 0.9991 - val_loss: 0.0845 - val_accuracy: 0.9837\n",
      "Epoch 39/100\n",
      "2538/2538 [==============================] - 4s 1ms/sample - loss: 0.0041 - accuracy: 0.9991 - val_loss: 0.0894 - val_accuracy: 0.9834\n",
      "Epoch 40/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0037 - accuracy: 0.9993 - val_loss: 0.0855 - val_accuracy: 0.9839\n",
      "Epoch 41/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0037 - accuracy: 0.9993 - val_loss: 0.0864 - val_accuracy: 0.9841\n",
      "Epoch 42/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0032 - accuracy: 0.9995 - val_loss: 0.0847 - val_accuracy: 0.9842\n",
      "Epoch 43/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0031 - accuracy: 0.9995 - val_loss: 0.0875 - val_accuracy: 0.9838\n",
      "Epoch 44/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0031 - accuracy: 0.9994 - val_loss: 0.0888 - val_accuracy: 0.9838\n",
      "Epoch 45/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0027 - accuracy: 0.9995 - val_loss: 0.0898 - val_accuracy: 0.9828\n",
      "Epoch 46/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0025 - accuracy: 0.9996 - val_loss: 0.0930 - val_accuracy: 0.9836\n",
      "Epoch 47/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0023 - accuracy: 0.9996 - val_loss: 0.0908 - val_accuracy: 0.9839\n",
      "Epoch 48/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0023 - accuracy: 0.9996 - val_loss: 0.0924 - val_accuracy: 0.9842\n",
      "Epoch 49/100\n",
      "2538/2538 [==============================] - 4s 1ms/sample - loss: 0.0022 - accuracy: 0.9996 - val_loss: 0.0898 - val_accuracy: 0.9839\n",
      "Epoch 50/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0020 - accuracy: 0.9996 - val_loss: 0.0957 - val_accuracy: 0.9841\n",
      "Epoch 51/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0020 - accuracy: 0.9997 - val_loss: 0.0928 - val_accuracy: 0.9842\n",
      "Epoch 52/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0019 - accuracy: 0.9997 - val_loss: 0.0942 - val_accuracy: 0.9839\n",
      "Epoch 53/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0017 - accuracy: 0.9997 - val_loss: 0.0976 - val_accuracy: 0.9842\n",
      "Epoch 54/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0016 - accuracy: 0.9997 - val_loss: 0.0918 - val_accuracy: 0.9841\n",
      "Epoch 55/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0016 - accuracy: 0.9997 - val_loss: 0.0951 - val_accuracy: 0.9842\n",
      "Epoch 56/100\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0016 - accuracy: 0.9997 - val_loss: 0.0914 - val_accuracy: 0.9840\n",
      "Epoch 57/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0014 - accuracy: 0.9998 - val_loss: 0.0983 - val_accuracy: 0.9839\n",
      "Epoch 58/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0013 - accuracy: 0.9998 - val_loss: 0.0947 - val_accuracy: 0.9842\n",
      "Epoch 59/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0013 - accuracy: 0.9998 - val_loss: 0.0990 - val_accuracy: 0.9843\n",
      "Epoch 60/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0011 - accuracy: 0.9999 - val_loss: 0.0986 - val_accuracy: 0.9840\n",
      "Epoch 61/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 0.0014 - accuracy: 0.9997 - val_loss: 0.1017 - val_accuracy: 0.9842\n",
      "Epoch 62/100\n",
      "2538/2538 [==============================] - 4s 2ms/sample - loss: 0.0012 - accuracy: 0.9999 - val_loss: 0.0994 - val_accuracy: 0.9844\n",
      "Epoch 63/100\n",
      "2538/2538 [==============================] - 4s 1ms/sample - loss: 0.0011 - accuracy: 0.9999 - val_loss: 0.1001 - val_accuracy: 0.9840\n",
      "Epoch 64/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 9.6842e-04 - accuracy: 0.9998 - val_loss: 0.0996 - val_accuracy: 0.9845\n",
      "Epoch 65/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 9.5924e-04 - accuracy: 0.9999 - val_loss: 0.1010 - val_accuracy: 0.9842\n",
      "Epoch 66/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 9.1304e-04 - accuracy: 0.9999 - val_loss: 0.1027 - val_accuracy: 0.9842\n",
      "Epoch 67/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 9.2520e-04 - accuracy: 0.9999 - val_loss: 0.1002 - val_accuracy: 0.9841\n",
      "Epoch 68/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 8.8896e-04 - accuracy: 0.9999 - val_loss: 0.0977 - val_accuracy: 0.9841\n",
      "Epoch 69/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 9.1310e-04 - accuracy: 0.9999 - val_loss: 0.1018 - val_accuracy: 0.9841\n",
      "Epoch 70/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 8.3093e-04 - accuracy: 0.9999 - val_loss: 0.1031 - val_accuracy: 0.9840\n",
      "Epoch 71/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 9.3341e-04 - accuracy: 0.9999 - val_loss: 0.1001 - val_accuracy: 0.9842\n",
      "Epoch 72/100\n",
      "2538/2538 [==============================] - 4s 1ms/sample - loss: 8.6405e-04 - accuracy: 0.9999 - val_loss: 0.1017 - val_accuracy: 0.9842\n",
      "Epoch 73/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 9.0216e-04 - accuracy: 0.9999 - val_loss: 0.1048 - val_accuracy: 0.9841\n",
      "Epoch 74/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 7.7404e-04 - accuracy: 0.9999 - val_loss: 0.0992 - val_accuracy: 0.9841\n",
      "Epoch 75/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 8.0419e-04 - accuracy: 0.9998 - val_loss: 0.1081 - val_accuracy: 0.9837\n",
      "Epoch 76/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 7.1732e-04 - accuracy: 0.9999 - val_loss: 0.1019 - val_accuracy: 0.9839\n",
      "Epoch 77/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 6.0964e-04 - accuracy: 1.0000 - val_loss: 0.1052 - val_accuracy: 0.9843\n",
      "Epoch 78/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 5.9022e-04 - accuracy: 0.9999 - val_loss: 0.1031 - val_accuracy: 0.9840\n",
      "Epoch 79/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 5.9063e-04 - accuracy: 0.9999 - val_loss: 0.1035 - val_accuracy: 0.9836\n",
      "Epoch 80/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 5.6342e-04 - accuracy: 1.0000 - val_loss: 0.1096 - val_accuracy: 0.9841\n",
      "Epoch 81/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 7.5302e-04 - accuracy: 0.9999 - val_loss: 0.1054 - val_accuracy: 0.9834\n",
      "Epoch 82/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 7.4551e-04 - accuracy: 0.9999 - val_loss: 0.1142 - val_accuracy: 0.9838\n",
      "Epoch 83/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 6.3261e-04 - accuracy: 0.9999 - val_loss: 0.1056 - val_accuracy: 0.9847\n",
      "Epoch 84/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 6.1627e-04 - accuracy: 0.9999 - val_loss: 0.1078 - val_accuracy: 0.9839\n",
      "Epoch 85/100\n",
      "2538/2538 [==============================] - 4s 1ms/sample - loss: 5.0132e-04 - accuracy: 1.0000 - val_loss: 0.1092 - val_accuracy: 0.9843\n",
      "Epoch 86/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 4.8457e-04 - accuracy: 1.0000 - val_loss: 0.1091 - val_accuracy: 0.9840\n",
      "Epoch 87/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 4.6094e-04 - accuracy: 0.9999 - val_loss: 0.1053 - val_accuracy: 0.9833\n",
      "Epoch 88/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 4.6435e-04 - accuracy: 1.0000 - val_loss: 0.1070 - val_accuracy: 0.9841\n",
      "Epoch 89/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 5.0181e-04 - accuracy: 0.9999 - val_loss: 0.1082 - val_accuracy: 0.9841\n",
      "Epoch 90/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 3.9998e-04 - accuracy: 1.0000 - val_loss: 0.1123 - val_accuracy: 0.9844\n",
      "Epoch 91/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 4.5237e-04 - accuracy: 0.9999 - val_loss: 0.1101 - val_accuracy: 0.9842\n",
      "Epoch 92/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 5.8398e-04 - accuracy: 0.9999 - val_loss: 0.1068 - val_accuracy: 0.9841\n",
      "Epoch 93/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 4.4173e-04 - accuracy: 0.9999 - val_loss: 0.1078 - val_accuracy: 0.9846\n",
      "Epoch 94/100\n",
      "2538/2538 [==============================] - 4s 2ms/sample - loss: 3.2640e-04 - accuracy: 1.0000 - val_loss: 0.1099 - val_accuracy: 0.9841\n",
      "Epoch 95/100\n",
      "2538/2538 [==============================] - 4s 1ms/sample - loss: 3.3532e-04 - accuracy: 1.0000 - val_loss: 0.1074 - val_accuracy: 0.9842\n",
      "Epoch 96/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 3.0379e-04 - accuracy: 1.0000 - val_loss: 0.1093 - val_accuracy: 0.9843\n",
      "Epoch 97/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 3.3618e-04 - accuracy: 1.0000 - val_loss: 0.1096 - val_accuracy: 0.9846\n",
      "Epoch 98/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 3.3063e-04 - accuracy: 1.0000 - val_loss: 0.1111 - val_accuracy: 0.9844\n",
      "Epoch 99/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 3.4341e-04 - accuracy: 1.0000 - val_loss: 0.1122 - val_accuracy: 0.9839\n",
      "Epoch 100/100\n",
      "2538/2538 [==============================] - 3s 1ms/sample - loss: 3.0126e-04 - accuracy: 1.0000 - val_loss: 0.1114 - val_accuracy: 0.9845\n"
     ]
    }
   ],
   "source": [
    "file_path = \"mer.h5\"\n",
    "BATCH_SIZE = 64\n",
    "\n",
    "checkpoint = ModelCheckpoint(file_path, monitor='val_loss', verbose=1, save_best_only=True, mode='min')\n",
    "es = EarlyStopping(monitor='val_loss', mode='min', verbose=1, patience=5)\n",
    "reduce_ = ReduceLROnPlateau(monitor=\"val_loss\", mode='min', patience=5, min_lr=1e-7)\n",
    "\n",
    "history = model.fit(train_sent, train_labels, batch_size = BATCH_SIZE, validation_data= (val_sent, val_labels), epochs = 100, callbacks=[es, checkpoint, reduce_], verbose = 1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[<matplotlib.lines.Line2D at 0x13e739f90>]"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.plot(history.history['val_loss'])\n",
    "plt.plot(history.history['loss'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1905/1905 [==============================] - 0s 256us/sample - loss: 0.1159 - accuracy: 0.9837\n"
     ]
    }
   ],
   "source": [
    "loss, acc = model.evaluate(test_sent, test_labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.9837375"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "acc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
